UNITED STATES SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a)
of the
Securities Exchange Act of 1934
|
Filed by the Registrant x
|
|
Filed by a Party other than the Registrant ☐
|
|
Check the appropriate box:
|
☐
|
Preliminary Proxy Statement
|
☐
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
x
|
Definitive Proxy Statement
|
☐
|
Definitive Additional Materials
|
☐
|
Soliciting Material Pursuant to §240.14a-12
|
Applied Minerals, Inc.
(Name of Registrant as Specified In Its
Charter)
(Name of Person(s) Filing Proxy Statement,
if other than the Registrant)
|
Payment of Filing Fee (Check the appropriate box):
|
☐
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
|
|
(1)
|
Title of each class of securities to which transaction applies:
|
|
(2)
|
Aggregate number of securities to which transaction applies:
|
|
(3)
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
(4)
|
Proposed maximum aggregate value of transaction:
|
☐
|
Fee paid previously with preliminary materials.
|
☐
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
|
(1)
|
Amount Previously Paid:
|
|
(2)
|
Form, Schedule or Registration Statement No.:
|
Persons who are to respond to the collection
of information contained in this form are not
required to respond unless the form displays
a currently valid OMB control number.
Applied Minerals, Inc.
Notice of 2020 Annual Meeting and
Proxy Statement
Annual Meeting of Stockholders
December 30, 2020 at 3:00 PM Eastern
Time
www.virtualshareholdermeeting.com/AMNL2020
November 20, 2020
Dear Stockholders:
We invite you to attend the Annual Meeting
of Applied Minerals, Inc., which will be held virtually at 3:00 PM on December 30, 2020 at www.virtualshareholdermeeting.com/AMNL2020. The
attached Notice of Annual Meeting and Proxy Statement give details of the business to be conducted at the meeting.
Presentation at the Meeting and
Q&A
At the Annual Meeting, we will have a full
presentation of our achievements since the last Annual Meeting and our objectives for 2021. There will be a question and
answer session at the meeting.
How to Vote
Record Owners: Mail.
Use the proxy card delivered with the proxy statement, sign it, and and mail it back in the self-addressed envelope
we have supplied or by mailing the proxy card to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717.
Internet. Go to proxyvote.com
and follow the directions. Please have the proxy card in hand when accessing proxyvote.com because you will
need the 16-digit control number on the proxy card. Or scan the QR Barcode on your proxy card and vote immediately, if
you have a QR Barcode reader.
Telephone. Use any touch-tone
telephone to call 1-800-690-6903 and follow the instructions. Please have the proxy card in hand when accessing proxyvote.com because
you will need the 16-digit control number on the proxy card.
At the meeting. You may vote
at the meeting with proper identification
Beneficial owners. Voting
instruction form. You will receive from your broker or custodian a voting instruction form (or other means) to instruct
your broker or custodian how to vote. Follow the directions on the form in order to vote. In order for your shares to be voted
on the election of directors and executive compensation (Say-on-Pay), you must provide instructions.
At the meeting. Beneficial
owners who wish to vote at the meeting must obtain from the broker or custodian a written authorization for the beneficial owner
to vote the beneficial owner’s shares.
* * * *
We hope that you will attend the meeting
or listen in to the webcast of the meeting. We look forward to talking with as many of you as possible.
Very Truly Yours,
Your Board of Directors
APPLIED MINERALS. INC.
Notice of 2020 Annual Meeting
of Stockholders
Date:
|
December 30, 2020
|
|
|
Time:
|
3:00 PM Eastern Time
|
|
|
Location:
|
www.virtualshareholdermeeting.com/AMNL2020
|
|
|
Record date:
|
November 9, 2020. Only stockholders of record at the close of business on the record date are entitled to receive notice of, and to vote at, the Annual Meeting.
|
|
|
Items of business:
|
●
|
To elect five directors to serve until the next Annual Meeting of Stockholders or until their respective successors are elected and qualified or they resign or are removed.
|
|
|
|
|
●
|
To approve, on a non-binding advisory basis, the compensation that has been paid to our Named Executive Officers
|
|
|
|
|
●
|
To ratify the selection of MaloneBailey LLP as our independent auditor for fiscal year 2020
|
|
|
|
|
●
|
To transact other business that may properly come before the Annual Meeting
|
By order of the Board of Directors
/s/ Christopher T. Carney
|
|
Christopher T. Carney
|
|
President, CEO and Secretary
|
|
New York, New York
|
|
November 20, 2020
|
|
Part 1: Information about the Meeting
This Proxy Statement was first sent, given,
or released to stockholders on November 20, 2020. It is furnished in connection with the solicitation of proxies. The
proxies are to be voted at the Annual Meeting of Stockholders of Applied Minerals Inc. (the “Company”) for
the purposes set forth in the accompanying Notice of Annual Meeting. The meeting will be held virtually at 3:00 PM Eastern
Time on December 30, 2020 at www.virtualshareholdermeeting.com/AMNL2020.
Stockholders who execute proxies retain
the right to revoke them at any time before the shares are voted by proxy at the meeting. A stockholder may revoke a proxy by delivering
a signed statement to our Corporate Secretary revoking the proxy at or prior to the Annual Meeting, or by timely executing
and delivering, by Internet, mail, or in person at the Annual Meeting, another proxy dated as of a later date.
Internet Availability of Proxy Materials
We are furnishing proxy materials to our
stockholders primarily via the Internet instead of mailing printed copies of those materials to each stockholder. By doing so,
we save costs and reduce the environmental impact of our Annual Meeting. On November 20, 2020, we mailed a Notice of Internet Availability
of Proxy Materials to our stockholders. The Notice of Internet Availability of Proxy Materials contains instructions about how
to access our proxy materials and vote online. If you would like to receive a paper copy of our proxy materials, please follow
the instructions included in the Notice of Internet Availability of Proxy Materials. If you previously chose to receive our proxy
materials electronically, you will continue to receive access to these materials via e-mail unless you elect otherwise.
How to Vote
Record Owners: You
may vote by mail. You can vote by mail using the proxy card delivered with the proxy statement, if you requested a paper
proxy statement, and mailing it back in the self-addressed envelope we have supplied or by mailing the proxy card to Vote Processing,
c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717. Proxy cards submitted by mail must be received by the time of the Annual Meeting
for your shares to be voted.
You may vote by Internet. You
can vote by Internet by going to proxyvote.com and following the directions. Please have the proxy card
or the Notice of Internet Availability in hand when accessing proxyvote.com because you will need the 16-digit control number
on the proxy card or the Notice of Internet Availability. Or you can scan the QR Barcode on your proxy card and vote immediately, if
you have a QR Barcode reader.
You may vote by phone. Use
any touch-tone telephone to call 1-800-690-6903 and follow the instructions. Please have the proxy card or the Notice of Internet
Availability in hand when accessing proxyvote.com because you will need the 16-digit control number on the proxy card or the Notice
of Internet Availability.
You can use the Internet or telephone to
transmit voting instructions up until 11:59 P.M. Eastern Time on December 29, 2020. Internet and telephone voting facilities for
record holders are available 24 hours a day. If you do not have the 16-digit control number, you may contact Broadridge Shareholder
Services at 877-830-4936 or shareholder@broadridge.com.
Beneficial
owners. Voting instruction form. You will receive from your broker or custodian a voting
instruction form (or other means) to instruct your broker or custodian how to vote. Follow the directions on the form in order
to vote. PLEASE PROVIDE VOTING INSTRUCTIONS AS TO ALL OF THE PROPOSALS TO BE VOTED ON. IN ORDER FOR YOUR SHARES TO BE VOTED
ON THE FOLLOWING PROPOSALS — THE ELECTION OF DIRECTORS AND EXECUTIVE COMPENSATION (SAY-ON-PAY) --- YOU MUST
PROVIDE INSTRUCTIONS.
Voting at the meeting. If
you wish to vote at the meeting, you must obtain from your broker or custodian, and present at the meeting, a “legal proxy,”
which is a written authorization from the broker or custodian authorizing the beneficial owner to vote the beneficial owner’s
shares at the meeting.
Webcast of Meeting; Asking Questions
The meeting will be webcast at www.virtualshareholdermeeting.com/AMNL2020.
Stockholders and others may listen to the meeting by logging into that address.
To ask questions if you are listening to
the webcast, you will need the 16-digit control number on the Notice of Internet Availability, your proxy card, or on the voting
instruction form sent by your broker or custodian.
Solicitation of Proxies
The Board of Directors of the Company is
soliciting the proxy accompanying this Proxy Statement. Proxies may be solicited by officers, directors, and employees of the Company,
none of whom will receive any additional compensation for their services. These solicitations may be made personally or by mail,
facsimile, telephone, messenger, email, or the Internet. The Company will pay persons holding shares of Common Stock in their names
or in the names of nominees, but not owning such shares beneficially (such as brokerage houses, banks, and other fiduciaries) for
the expense of forwarding solicitation materials to their principals. The Company will pay all proxy solicitation costs.
Householding
To reduce costs and reduce the environmental
impact of our Annual Meeting, a single proxy statement, annual report, and Form 10-Q for the three months ended September 30, 2020
will be delivered in one envelope to certain stockholders having the same last name and address and to individuals with more than
one account registered at our transfer agent with the same address, unless contrary instructions have been received from an affected
stockholder. Stockholders participating in householding will continue to receive separate proxy cards. If you are a registered
stockholder and would like to enroll in this service or receive individual copies of this year’s and/or future proxy materials,
please contact our transfer agent, Broadridge Corporate Issuer Solutions, by phone at (800) 542-1061 or mail at Broadridge,
Householding Department, 51 Mercedes Way, Edgewood, New York 11717. If you are a beneficial stockholder, you may contact the broker
or bank where you hold the account.
Record Date; Shares Eligible to Vote;
Quorum
Stockholders of record at the close of
business on November 9, 2020 will be entitled to vote at the meeting on the basis of one vote for each share held. On November
9, 2020, there were 175,638,549,shares of Common Stock outstanding and 595 record holders of the Company’s Common Stock.
The presence of the holders of a majority
of the outstanding shares of Common Stock entitled to vote at the Annual Meeting (87,994,913 shares), in person or represented
by proxy, is necessary to constitute a quorum. Abstentions and “broker non-votes” are counted as “present and
entitled to vote” for purposes of determining a quorum.
Election of Directors
Five directors are to be elected at the
Annual Meeting to hold office until the next Annual Meeting of Stockholders or until their respective successors are elected and
qualified or until such director's earlier resignation or removal.
The Board of Directors expects that each
of the nominees will be available for election, but if any of them is unable to serve at the time the election occurs, the proxy
will be voted for the election of another nominee designated by our Board.
If, for any reason, the directors are not
elected at an Annual Meeting, they may be elected at a special meeting of stockholders called for that purpose in the manner provided
by the By-Laws of the Company (“By-Laws”).
Voting Procedures and Votes Required
for Election of Directors and Approval of Proposals
Voting of proxies
All proxies solicited by the Company, whether
received by means of a proxy card, telephone, or the Internet, will be voted, and where a choice is made with respect to a matter
to be voted on, the shares will be voted in accordance with the specifications so made.
Except for broker non-votes (explained
below), if a proxy is submitted without indicating that the shares are to be cast (i) FOR all nominees (ii) WITHHOLD
for all nominees or (iii) FOR all except specified nominee(s), it will be deemed to grant authority to vote FOR all nominees to
serve as directors as set forth in Part 7 – “Proposals to be voted on” and discussed in Part 2 “Information
concerning Directors“.
Except for broker non-votes, if a proxy
is submitted without indicating voting instructions on Proposal 2 (Say-on-Pay), Proposal 3 (advisory vote to approve the frequency
of the advisory vote to approve the compensation of the company’s named executive officers) or Proposal 4 (ratification of
independent auditor), it will be deemed to grant authority to vote FOR the Proposal(s) as to which no instruction is given.
Voting of shares held of record,
but not beneficially, by brokers and other custodians
Beneficial owners will receive a voting
instruction form or other means, as specified by the broker or custodian, to instruct your broker, custodian, or other fiduciary
how to vote. Beneficial owners may instruct the broker or custodian or other fiduciaries how to vote the shares
through the voting instruction form or other means. If you wish to vote the shares you own beneficially at the meeting, you must
request and obtain from your broker or other custodian and bring to the meeting, a “legal proxy” (a written authorization
from the broker or custodian authorizing you to vote at the meeting).
Tabulation of shares present at meeting and tabulation
of votes
Employees of the Company will tabulate
the shares present at the meeting and the votes cast. We expect to report the final vote tabulation on a Form 8-K filed with the
SEC within four business days of the Annual Meeting.
Vote standard for election of directors;
additional nominations
The directors will be elected by a plurality
of the votes cast, meaning the directors receiving the largest number of “FOR” votes will be elected to the open positions.
The Company’s By-Laws contain advance notice provisions for nominations for director by stockholders. If a stockholder makes
a nomination that is not made in accordance with such advance-notice provisions, the nomination may not be voted on at the meeting.
As of the date of this proxy statement, the date for stockholder to comply with the advance notice provisions, and thus to be eligible
to make a nomination at the meeting, has passed
Broker Non-Votes
If you are the beneficial owner of shares
held by a broker or other custodian and you instruct the broker or custodian to vote but choose not to provide instructions as
to one or more ballot items, your shares are referred to as “uninstructed shares” as to the ballot items on which you
do not provide instructions. Whether your broker or custodian has the discretion to vote these shares on your behalf depends on
the ballot item. See table below. If the broker or custodian has discretion, the broker or custodian may vote as it chooses. If
the broker or custodian does not have discretion to vote on a proposal, the shares will not be voted on that proposal and are referred
to as “broker non-votes” as to that proposal.
Quorum
Shares represented by proxies submitted
without instructions or with instructions only on some issues or with withhold or abstentions as well as shares represented by broker
non-votes will be included in the number of shares present at the Annual Meeting to determine whether a quorum is present.
Vote required for approval
The following table summarizes the votes
required for passage of each proposal, the effect of abstentions on the voting of shares, and the effect of uninstructed shares
held by brokers or other custodians on the voting of such shares.
|
|
Votes Required for
Approval
|
|
Abstentions
Is Vote Cast or Not
Cast?
|
|
Broker Non-Votes
Is Vote Cast or Not
Cast?
|
|
|
|
|
|
|
|
Election of directors
|
|
Plurality of shares cast
|
|
Vote not cast
|
|
Vote not cast
|
|
|
|
|
|
|
|
Advisory vote on executive compensation (“Say-on-Pay”)
|
|
Majority of shares cast
|
|
Vote not cast
|
|
Vote not cast
|
|
|
|
|
|
|
|
Ratification of independent auditor
|
|
Majority of shares cast
|
|
Vote not cast
|
|
Broker or custodian may vote using its discretion
|
Voting on Other Matters
Under the Company’s By-Laws, if other
matters in addition to those listed in the Notice are properly presented at the Annual Meeting for consideration, the persons appointed
as proxies by the Board of Directors (the persons named on your proxy card if you are a stockholder of record) will have the discretion
to vote the proxies they hold on those matters for you and will follow the instructions of the Board of Directors. However, the
Company’s By-Laws contain advance notice provisions for proposals to be made by stockholders. If a stockholder offers a proposal
for a vote that is not made in accordance with such advance-notice provisions, the proposal may not be voted on at the meeting.
As of the date of this proxy statement, the date for a stockholder to comply with the advance notice provisions, and thus to be
eligible to make a proposal at the meeting, has passed.
Part 2 Information concerning Directors
Nominees for Director
The Company’s directors are to
be elected at each Annual Meeting of Stockholders. The Company’s Certificate of Incorporation provides that the number of
directors is to be fixed from time to time by resolution of the Board of Directors, and the Board of Directors has fixed the number
at five.
At this Annual Meeting, five directors
are to be elected, and each director to serve until the next Annual Meeting of Stockholders or until such director’s successor
is elected and qualified or such director resigns or is removed. The Board of Directors’ nominees for the Board of
Directors are:
|
●
|
Mario Concha
|
|
|
|
|
●
|
John Levy
|
|
|
|
|
●
|
Robert Betz
|
|
|
|
|
●
|
Geoffrey Scott
|
|
|
|
|
●
|
Christopher Carney
|
Information about Nominees
The following table provides the names,
ages, positions with the Company, and principal occupations of our current directors who have been nominated for election as a
director at the Annual Meeting:
Name and Position
with The Company
|
Age
|
Director/Officer Since
|
|
Principal Occupation
|
|
|
|
|
|
Mario Concha
|
80
|
Chairman since 2016; Director since 2013
|
|
President, Mario Concha and Associates
|
|
|
|
|
|
John F. Levy
|
65
|
Vice Chairman since 2016; Director since 2008
|
|
CEO of Board Advisory Services
|
|
|
|
|
|
Robert T. Betz
|
78
|
Director since 2014
|
|
Owner, Personal Care Ingredients
|
|
|
|
|
|
Geoffrey Scott
|
72
|
Director since June 2018
|
|
Private Investor
|
|
|
|
|
|
Christopher T. Carney
|
50
|
President and CEO since October 2020, Director since 2020
|
|
President, CEO and CFO of the Company
|
All of the nominees are incumbents and
their current terms expire at the 2020 Annual Meeting.
Information about persons nominated by
the Board of Directors for the position of director of the Company is listed below, including brief biographies. Each biographic
summary is followed by a brief summary of certain experiences, qualifications, attributes or skills that led the Board to determine
that each nominee is qualified to, and should, serve as a director for the Company. General information regarding the nomination
process is included under the “Governance and Nominating Committee and Nomination Process” heading.
Mario Concha, Chairman and Director
Mr. Concha is President of Mario Concha
and Associates, a firm providing consulting services to senior executives and boards of directors. He serves on the board of the
National Association of Corporate Directors, Atlanta Chapter. He has served as a director of Arclin, Ltd., a manufacturer of specialty
resins, and Auro Resources, Corp, a mineral exploration company with holdings in Colombia’s gold region. Mr. Concha
was an officer of Georgia Pacific Corporation and president of its Chemical Division from 1998 to 2005. Prior to Georgia
Pacific, Mr. Concha participated in the formation of GS Industries, a manufacturer of specialty steels for the mining industry,
through a leveraged buyout of Armco Inc.’s Worldwide Grinding Systems Division. He then served as President of its
International Division from 1992 to 1998. From 1985 to 1992, Mr. Concha was Vice President-International for Occidental Chemical
Corporation. Prior to Occidental Chemical, he served in several senior management positions at Union Carbide Corporation
in the United States and overseas.
Mr. Concha is a graduate of Cornell University
with a degree in Chemical Engineering. He has attended the Advanced Management Program at the University of Virginia's
Darden School of Business and the NACD-ISS accredited Director's College at the University of Georgia's Terry College of Business.
He is a member of the National Association of Corporate Directors, the American Chemical Society, and the American Institute
of Chemical Engineers.
Key attributes, experience and skills: Mr.
Concha has over 40 years experience as a hands-on corporate executive. He has first-hand industry knowledge, gained from
senior executive positions in various industries, including chemicals, plastics, forest products, metals, and mining. In
addition to manufacturing operations, he has had extensive involvement in marketing, sales, and finance. Mr. Concha also
brings corporate governance experience, having served on both public and private company boards.
John F. Levy, Vice Chairman and Director
Since
May 2005, Mr. Levy has served as the Chief Executive Officer of Board Advisory, a consulting firm that advises public companies
in the areas of corporate governance, corporate compliance, financial reporting, and financial strategies. Mr. Levy served as
the Chief Executive Officer of Sticky Fingers Restaurant, LLC, a South Carolina based barbeque restaurant chain, and has held
this position from August 2019 to May 2020. Mr. Levy previously served as a business consultant with Sticky Fingers Restaurants,
LLC from February 2019 to August 2019. In addition to his service on Applied Minerals, Inc. board of directors, Mr. Levy
has been a director, chairman of the Audit Committee, and a member of the Governance and Nominating Committee, of Washington Prime
Group, a Real Estate Investment Trust, since 2016 and Happiness Biotech Group Limited (since October 2019), a Chinese-based
nutraceutical and dietary supplements company. Mr. Levy was a director,
chairman of the Governance and Nominating Committee, and a member of the Audit and Compensation Committees of Takung Art Co.,
Ltd., an operator of an electronic online platform for artists, art dealers and art investors to offer and trade in ownership
units over valuable artwork from February 2016 to June 2019. He was a director of China Commercial Credit, a publicly held Chinese
micro-lender, from 2013 to 2016. He was a director and audit committee member of Applied Energetics, Inc. (AERG), a publicly held
company that specialized in the development and application of high power lasers, high voltage electronics, advanced optical systems
and energy management systems technologies from 2009 to 2016.
From
2006 to 2013, Mr. Levy was a director and chair of the Audit Committee of Gilman Ciocia, Inc., a publicly traded financial planning
and tax preparation firm and served as lead director from 2007 to 2013. From 2010 to 2012, he served as director of Brightpoint,
Inc., a publicly traded company that provides supply chain solutions to leading stakeholders in the wireless industry. From 2008
through 2010, he served as a director of Applied Natural Gas Fuels, Inc. (formerly PNG Ventures, Inc.). From 2006 to 2010, Mr.
Levy served as a director and Audit Committee chairman of Take Two Interactive Software, Inc., a public company that is a global
developer and publisher of video games best known for the Grand Theft Auto franchise. Mr. Levy is a frequent speaker on
the roles and responsibilities of Board members and audit committee members. He has authored The 21st Century Director:
Ethical and Legal Responsibilities of Board Members, Acquisitions to Grow the Business: Structure, Due Diligence,
Financing, Ethics and Sustainability: A 4-way Path to Success, Finance and Innovation: Reinvent Your Department and
Your Company, Predicting the Future: 21st Century Budgets and Projections and Heartfelt Leadership: How Ethical
Leaders Build Trusting Organizations. All courses have been presented to state accounting societies. Mr. Levy is a Certified
Public Accountant with several years of experience. Mr. Levy is a graduate of the Wharton School of the University of Pennsylvania,
and received his MBA from St. Joseph's University in Philadelphia. Mr. Levy has completed the National Association of Corporate
Directors’ Board Leadership Fellow program of study.
Key
attributes, experience and skills: Mr. Levy has over 35 years of progressive financial, accounting, and business experience,
including having served as Chief Financial Officer of both public and private companies for over 13 years. Mr. Levy
brings to the board expertise in corporate governance and compliance matters along with extensive experience gained from numerous
senior executive positions with public companies. Further, Mr. Levy’s service on the boards of directors of public companies
in a variety of industries allows him to bring a diverse blend of experiences to the Company’s board.
Robert T. Betz, Director
From 2000 through his retirement in 2002,
Mr. Betz was the President of Cognis Corp., the North American division of Cognis GmbH, a $4 billion worldwide supplier of specialty
chemicals and nutritional ingredients that was spun off from Henkel AG & Company ("Henkel"). From 1989 through
2000, Mr. Betz held a number of management positions at Henkel, including Executive VP and President of its Emery Group, a leading
manufacturer of oleochemicals, and President of its Chemicals Group for North America.
From 1979 through 1989, Mr. Betz worked
in a number of manufacturing and operations capacities for the Emery Division of National Distillers and Chemicals Corp., eventually
rising to President of the division. Mr. Betz began his career in the specialty chemicals industry by joining Emery Industries
in 1963. Between 1963 and 1979 he worked for the company as Market Development Representative, Manager of Corporate Planning,
Vice President of Operations - Emery (Canada), Manager of Commercial Development, and General Manager of Business Groups. Emery
Industries was sold to National Distillers and Chemicals Corp. in 1979.
Since 2003, Mr. Betz has been the owner
of Personal Care Ingredients, LLC, a privately-owned marketer of natural products to the personal care industry. Mr. Betz
also serves as a director for Bio-Botanica, a manufacturer of natural extracts.
Mr. Betz holds a B.S. in Chemical Engineering
and an M.B.A., both degrees from the University of Cincinnati. He has also attended the Program for Management Development
at Harvard University.
Key attributes experience and skills. During
Mr. Betz’s career, he has been involved in developing new products or new markets for existing products. Several of these
products grew into sizeable businesses. He managed multiple chemical manufacturing facilities and managed a multi-billion
dollar polyethylene business. He was responsible for profit and loss for businesses with sales of $900 million. While heading the
chemical operations, he was responsible for all aspects of the business: manufacturing, sales, R&D, IT, HS&E, HR, purchasing,
engineering, and legal. His career has continuously involved developing, manufacturing, and selling products directed at most of
the markets that Applied Minerals is attempting to penetrate. Since his retirement, he served on the boards of three chemical-related,
private companies: Plaza Group, Syrgis, and Bio-Botanica.
Geoffrey Scott, Director
Mr. Scott is a private investor. From 1995 to 2018, Mr. Scott
was an investment advisor and president of Scott Asset Management, whose clients were high net worth individuals. From
1990 to 1995, he was a vice president, corporate finance at Merrill Lynch. From 1973 to 1990, he was a vice president of
corporate banking at Chase Manhattan Bank.
Key attributes, experience and skills: For
10 years, he served on the Board of a private company, growing revenue from approximately $50 million to $150 million. In
a quickly growing company, allocation of resources is a very important consideration. He served on the audit and compensation
committees. The company was eventually sold to a private equity buyer. His experience with charting the growth of smaller
companies will be of value to the Board of the Company.
Christopher T. Carney, Chief Executive
Officer, President, Chief Financial Officer, Director
Mr. Carney is President and CEO and has
served in those positions since October 22, 2020. Mr. Carney has also served as the Company’s CFO since August 2015.
From February 2009 through May 2012, Mr.
Carney was the Interim Chief Financial Officer of the Company. From May 2012 through August 2015, Mr. Carney was a VP of Business
Development for the Company. Mr. Carney was appointed Chief Financial Officer of the Company in August 2015 when the previous Chief
Financial Officer resigned. He retained his position as Vice President of Business Development. From March 2007 until December
2008, Mr. Carney was an analyst at SAC Capital/CR Intrinsic Investors, LLC, a hedge fund, where he evaluated the debt and equity
securities of companies undergoing financial restructurings and/or operational turnarounds. From March 2004 until October 2006,
Mr. Carney was a distressed debt and special situations analyst for RBC Dain Rauscher Inc., a registered broker-dealer. Mr. Carney
graduated with a BA in Computer Science from Lehman College and an MBA in Finance from Tulane University.
Key attributes, experience and skills:
He has worked for the Company in a number of capacities since January 2009. Since August 2015 he has been the Company’s Chief
Financial Officer.
Who originally recommended the Nominees.
Mr. Levy was originally recommended for election as director by David Taft, President of IBS Capital, LLC, at the time
a significant stockholder and later a director. Mr. Concha was originally recommended by Mr. Levy. Mr. Betz was originally
recommended by Mr. Concha. Mr. Scott was recommended by former director and CEO, Andre Zeitoun. Mr. Carney was recommended by Mario
Concha.
Director Nomination Agreements
The Company entered into an director nomination
agreement (“Samlyn Director Nomination Agreement’) in 2011 in connection with a $10 million investment in the
Company with Samlyn Onshore Fund, LP, a Delaware limited partnership, and Samlyn Offshore Master Fund, Ltd., a Cayman Islands exempted
company (together the “Samlyn Funds”). Subject to the terms and conditions of the Samlyn Director Nomination Agreement,
until the occurrence of a Termination Event (as defined in the Samlyn Director Nomination Agreement), the Samlyn Funds jointly
have the right to designate one person to be nominated for election to the Board. In 2018, the Samlyn Funds exercised the right
to designate a person by designating Michael Barry, the General Counsel and Chief Compliance Officer of Samlyn Capital, LLC.
Mr. Barry resigned on October
20, 2020.
The Company entered into a director nomination
agreement (“2023 Director Nomination Agreement”) in 2017 with the Holders of the 10% PIK Election Convertible
Notes Due 2023 (“2023 Holders”). Subject to the terms and conditions of the 2023 Director Nomination Agreement, the
2023 Holders have the right the right to designate one person to be nominated for election to the Board. In 2017 the 2023 Holders
exercised that right to designate by designating Michael Pohly, who at the time was Portfolio Manager and Sector Head for Credit,
Currencies and Commodities at Kingdon Capital Management LLC.
Mr. Pohly resigned on April
13, 2020.
Director Compensation for the Year
Ended December 31, 2019
The following sets forth compensation to
our directors in 2019. The fees payable to directors are $50,000 per year and $10,000 per year for chairman of the Board and $10,000
per year for chairman of a committee, except the Operations Committee (“Board Fees”). The fees payable for the Operations
Committee are $150,000 for the chairman and $62,500 for the member who is an independent director (“Operations Committee
Fees”). Beginning the last quarter of 2018, Board Fees have been accrued but not paid. The accrued but not paid Board Fees
may be paid in cash or equity in the future, to be determined by the Board.
The following sets forth compensation to
our directors in 2019. Mr. Carney receives no fees for service as a director.
Name
|
|
Fees Earned
or
Paid in Cash ($)
|
|
|
Common
Stock
Awards ($)
|
|
|
Options
Awards
($)(3)
|
|
|
Total
($)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mario Concha
|
|
|
220,000
|
|
|
|
- 0 -
|
|
|
|
18,500
|
|
|
|
238,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
John Levy
|
|
|
70,000
|
|
|
|
- 0 -
|
|
|
|
18,500
|
|
|
|
88,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Robert Betz
|
|
|
132,500
|
|
|
|
- 0 -
|
|
|
|
18,500
|
|
|
|
141,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Geoffrey Scott (1)
|
|
|
39,861
|
|
|
|
- 0 -
|
|
|
|
18,500
|
|
|
|
58,361
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Michael Barry (2)
|
|
|
50,000
|
|
|
|
- 0 -
|
|
|
|
18,500
|
|
|
|
68,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Michael Pohly (4)
|
|
|
50,000
|
|
|
|
- 0 -
|
|
|
|
18,500
|
|
|
|
68,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ali Zamani (5)
|
|
|
50,000
|
|
|
|
- 0 -
|
|
|
|
18,500
|
|
|
|
68,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Andre Zeitoun (6)
|
|
|
- 0 -
|
|
|
|
- 0 -
|
|
|
|
- 0 -
|
|
|
|
- 0 -
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Alexandre Zyngier (7)
|
|
|
60,000
|
|
|
|
- 0 -
|
|
|
|
18,500
|
|
|
|
78,500
|
|
(1)
|
Mr. Scott was appointed a director on March 13, 2019
|
(2)
|
Mr. Barry resigned on October 20, 2020.
|
(3)
|
Black Scholes value at grant date.
|
(4)
|
Mr. Pohly resigned on April 13, 2020.
|
(5)
|
Mr. Zamani resigned on April 30, 2020.
|
(6)
|
Mr. Zeitoun resigned as CEO and director on September 8, 2020. He was not compensated for his work as a director.
|
(7)
|
Mr. Zyngier resigned on October 20, 2020.
|
Board Leadership
Through October 20, 2020, Alexandre Zyngier served as Lead Director.
The Lead Director facilitated the functioning of the Board of Directors independently of management of the Company and provided
independent leadership to the Board. In fulfilling his responsibilities, the Lead Director was responsible for: (a) providing leadership
to ensure that the Board functions independently of management of the Company and other non-independent directors; (b) working
with the Chair to ensure that the appropriate committee structure is in place and assisting the Governance and Nominating Committee
in making recommendations for appointment to such committees; (c) recommending to the Chair items for consideration on the agenda
for each meeting of the Board; (d) commenting to the Chair on the quality, quantity and timeliness of information provided by management
to the independent directors; (e) in the absence of the Chair, chairing Board meetings,; in addition, chairing each Board meeting
at which only outside directors or independent directors are present; (f) consulting and meeting with any or all of the independent
directors, at the discretion of either party and with or without the attendance of the Chair, and representing such directors,
where necessary, in discussions with management of the Company on corporate governance issues and other matters; and (g) working
with the Chair and the Chief Executive Officer to ensure that the Board is provided with the resources, including external advisers
and consultants to the Board as considered appropriate, to permit it to carry out its responsibilities and bringing to the attention
of the Chair and the Chief Executive Officer any issues that are preventing the Board from being able to carry out its responsibilities.
Mr. Zyngier served as Lead Director after Board Chair, Mario
Concha, assumed the role of CEO in September 2019. On October 20, 2020 Mr. Zyngier resigned as a director. On October 22, 2020
Mr. Concha resigned as CEO and Mr. Carney was appointed by the Board to replace Mr. Concha as CEO.
Mr. Concha, as the Board Chair, sets
the agenda for and presides at Board meetings and coordinates the Board’s communication with Mr. Carney and the management
of the Company. Since October 22, 2020, Mr. Concha is fully independent.
Mr. Carney, the Chief Executive Officer,
is responsible for, among other things, managing the business and affairs of the Company within the guidelines established by the
Board, reporting to the Board of Directors, recommending to the Board strategic directions for the Company’s business,
and implementing the strategic, business and, operational plans approved by the Board.
Director Independence
Messrs. Concha, Levy, Betz, and Scott are
deemed to be independent for purposes of the Board under the independence standards of Nasdaq, which the Company uses to determine
independence, and under the enhanced independence standards of Section 10A-3 of the Securities Exchange Act. They are also deemed
to be outside directors under the standards of Section 162(m) of the Internal Revenue Code.
Risk Oversight
The Board oversees management’s evaluation
and planning for risks that the Company faces. Management regularly discusses risk management at its internal meetings and reports
to the Board those risks that it thinks are most critical and what it is doing in response to those risks. The Board exercises
oversight by reviewing key strategic and financial plans with management at each of its regular quarterly meetings as well as at
certain special meetings. The Board’s risk oversight function is coordinated under the leadership of the independent Chair
of the Board and the Board believes that this oversight is enhanced by the separation of the role of Chair from CEO.
Code of Ethics
We have adopted a Code of Conduct and Ethics
for our Chief Executive Officer and our senior financial officers. A copy of our Code of Conduct and Ethics is posted
on our website at www.appliedminerals.com and can be obtained at no cost, by telephone at (435) 433-2059 or via mail by writing
to Applied Minerals, Inc., PO Box 432, Eureka, UT 84628. We believe our Code of Conduct and Ethics is reasonably designed
to deter wrongdoing and promote honest and ethical conduct; to provide full, fair, accurate, timely and understandable disclosure
in public reports; to comply with applicable laws; to ensure prompt internal reporting of code violations; and to provide accountability
for adherence to the Code.
Board and Committee Meetings and Meeting Attendance
During 2020, there were six meetings of the Board of Directors,
40 meetings of the Operations Committee, five meetings of the Compensation Committee, four meetings of the Audit Committee, and
four meetings each of the Governance and Nominating Committee and the Health, Safety and Environment Committee. Every director
attended at least 75% of all board meetings and all committee meetings of which that director was a member. It is the policy of
the Board that all Board members attend the annual meeting of shareholders, if possible.
Committees of the Board
The following sets forth the standing Committees
of the Board and membership of the committees. The charters of the committees are available at the Company’s website, appliedminerals.com.
The Board of Directors has determined that all committee members are independent under the independence definition used by NASDAQ
except for Mr. Zeitoun.
|
|
Audit Committee
|
|
Governance and
Nominating Committee
|
|
Compensation Committee
|
|
Health,
Safety and
Environment
Committee
|
|
Operations
Committee
|
Mario Concha
|
|
|
|
X
|
|
|
|
X
|
|
X
|
John Levy
|
|
X*
|
|
X*
|
|
X
|
|
|
|
|
Robert Betz
|
|
X
|
|
X
|
|
X*
|
|
X*
|
|
X*
|
Geoffrey Scott
|
|
X
|
|
|
|
X
|
|
|
|
|
Christopher T. Carney
|
|
|
|
|
|
|
|
|
|
|
* Committee Chairman
The Audit Committee satisfies the definition
of Audit Committee in Section 3(a)(58)(A) of the Securities Exchange Act of 1934.
Audit Committee Financial Expert
The Board of Directors has determined
that Mr. Scott and Mr. Levy each is an Audit Committee Financial Expert as the term is defined in the rules of the Securities
and Exchange Commission.
Audit Committee Report
The audit committee has reviewed
and discussed the audited financial statements included elsewhere in this Annual Report with management;
The audit committee has discussed
with the independent auditors the matters required to be discussed by the Auditing Standards AU Section 380 - The Auditor’s
Communication with those charged with Governance as adopted by the Public Company Accounting Oversight Board in Rule 3200T;
The audit committee has received
the written disclosures and the letter from the independent accountant required by applicable requirements of the Public Company
Accounting Oversight Board regarding the independent accountant's communications with the audit committee concerning independence
and has discussed with the independent accountant the independent accountant's independence; and
Based on the review and discussions
referred to in three preceding paragraphs, the audit committee recommended to the board of directors that the audited financial
statements be included in the Company's annual report on Form 10-K (17 CFR 249.310) for the last fiscal year for filing with the
Commission.
Governance and Nominating Committee
and Nomination Process.
The Governance and Nominating Committee
does not have a set process for identifying and evaluating nominees for director and does not have any specific minimum requirements
that must be met by any committee-recommended nominee for a position on the Board of Directors. Characteristics expected of all
directors include integrity, high personal and professional ethics, sound business judgment, and the ability and willingness to
commit sufficient time to the Board. In evaluating the suitability of individual Board members, the Board takes into account many
factors, including general understanding of marketing, finance, and other disciplines relevant to the success of a publicly-traded
company in today's business environment; understanding of the Company's business; educational and professional background; and
personal accomplishment. The Board evaluates each individual in the context of the Board as a whole, with the objective of
recommending a group that can best promote the success of the Company's business and represent stockholder interests through the
exercise of sound judgment. In determining whether to recommend a director for re-election, the Governance and Nominating Committee
also considers the director's past attendance and the results of the most recent Board self-evaluation.
The Board does not have a policy relating
to diversity in connection with the identification or selection of nominees and has not considered the issue.
The Board will consider director candidates
recommended by any stockholder. In evaluating candidates recommended by our stockholders, the Board of Directors has
no set process for evaluating nominees, and the criteria would include the ones set forth above that are applied to nominees nominated
by the Board. Any stockholder recommendations for director nominees proposed for consideration by the Board should include the
candidate's name and qualifications for service as a Board member, a document signed by the candidate indicating the candidate's
willingness to serve, if elected, and evidence of the stockholder's ownership of Company Common Stock and should be addressed
in writing to the Chairman, Applied Minerals, Inc., PO Box 432 Eureka, UT 84628.
There have been no changes in the procedures
by which stockholders may recommend candidates for director.
Samlyn Funds — Rights to Nominate
Directors
In connection with their investment
of $10 million in 2011, Samlyn Onshore Fund, LP, a Delaware limited partnership, and Samlyn Offshore Master Fund, Ltd., a Cayman
Islands exempted company (collectively, the “Samlyn Entities”) were granted the joint right to designate one person
(the “Initial Nominee”) to be nominated for election to the Board and the Board of Directors must use commercially
reasonable efforts to cause the election or appointment, as the case may be, of such nominee as a director of the Company.
If any nominee is jointly designated
by the Samlyn Entities at a time (A) at which such nominee cannot be included in the proxy statement prepared by management of
the Company in connection with the soliciting of proxies for a meeting of the stockholders of the Company called with respect to
the election of directors or (B) after which a meeting of the stockholders has been held with respect to the election of directors (collectively,
the “Interim Period”) or (ii) is nominated for election to the Board but not elected by the stockholders of the Company
for any reason whatsoever, the Board shall increase the number of members serving on the Board by one and the Samlyn Entities shall
be entitled to promptly designate a nominee, who shall be appointed by the Board to fill the additional member position promptly.
If the Samlyn Entities, together with their
respective affiliates, cease to beneficially own at least 9,700,000 shares of Common Stock, the rights of the Samlyn Entities described
above shall terminate automatically (the “Termination Event”). As promptly as practicable following the Termination
Event, at the request of the Board, the Samlyn Nominee shall cause such Nominee to execute and deliver a letter of resignation
to the Company, which resignation shall be effective immediately with respect to the Company and, if applicable, any subsidiary
of the Company for which such Nominee serves as a director, manager or other similar position.
The Samlyn Funds exercised the right
to designate a person in 2013 and in 2018. The 2013 nominee resigned from the Board in 2017. The 2018 nominee, Michael Barry, the
General Counsel and Chief Compliance Officer of Samlyn Capital, Ltd., was appointed to the Board in April 2018. At his direction,
Mr. Barry’s compensation as a director was paid to the Samlyn Funds. Mr. Barry resigned as a director on October 20, 2020.
Director Nomination Agreement with Series
2023 Noteholders
The Company has entered into a director
nomination agreement (“2023 Director Nomination Agreement’) in 2017 with the Holders of the 10% PIK Election Convertible
Notes Due 2023 (“2023 Holders”). Subject to the terms and conditions of the 2023 Director Nomination Agreement, the
2023 Holders have the right to designate one person to be nominated for election to the Board. The 2023 Holders designated Michael
Pohly, Portfolio Manager and Sector Head for Credit, Currencies and Commodities at Kingdon Capital Management LLC, as a director
and Mr. Pohly was appointed as a director. At his direction, Mr. Pohly’s compensation as a director was paid to M. Kingdon
Offshore Master Fund, L.P. Mr. Pohly resigned as a director on April 13, 2020.
If any nominee (i) is designated by the
at a time (A) at which such nominee cannot be included in the proxy statement prepared by management of the Company in connection
with the soliciting of proxies for a meeting of the stockholders of the Company called with respect to the election of Directors
or (B) after which a meeting of the stockholders has been held with respect to the election of Directors or (ii) is nominated for
election to the Board but not elected by the stockholders of the Company for any reason whatsoever (including, without limitation,
such Nominee’s death, disability, disqualification or withdrawal as a nominee), the Board shall increase the number of members
serving on the Board by one, if appropriate, and the noteholders shall be entitled to promptly designate a nominee by written notice
to the Company, who shall be appointed by the Board to fill such additional member position promptly. Such rights expire upon the
occurrence of a Termination Event as defined. A Termination Event occurs if the 2023 Holders, together with their respective Affiliates,
cease to Beneficially Own at least 80 per cent of the Series 2023 Notes that have been issued in the aggregate, whether as a result
of dilution, transfer, conversion, or otherwise.
Compensation Committee
The Compensation Committee is
required to meet at least twice a year. The Committee charter states that the Committee will have the resources and authority
necessary to discharge its duties and responsibilities and the Committee has sole authority to retain and terminate outside counsel,
compensation consultants, or other experts or consultants, as it deems appropriate, including sole authority to approve the fees
and other retention terms for such persons.
The principal responsibilities of the Compensation Committee
are as follows:
|
1.
|
Board Compensation.
Periodically review the compensation paid to non-employee directors and make recommendations to the Board for any adjustments.
|
|
2.
|
Chief Executive Officer Compensation.
|
|
a.
|
Conduct an annual CEO evaluation.
|
|
b.
|
Assist the Board in establishing CEO annual goals and objectives, if appropriate.
|
|
c.
|
Recommend CEO compensation to the other independent members of the Board for approval.
|
|
|
(The CEO may not be present during deliberations or voting concerning the CEO's compensation.)
|
|
3.
|
Other Executive Officer Compensation.
|
|
a.
|
Oversee an evaluation of the performance of the Company's executive officers and approve the annual compensation, including salary and incentive compensation, for the executive officers.
|
|
b.
|
Review the structure and competitiveness of the Company’s executive officer compensation programs considering the following factors: (i) the attraction and retention of executive officers; (ii) the motivation of executive officers to achieve the Company’s business objectives; and (iii) the alignment of the interests of executive officers with the long-term interests of the Company’s stockholders.
|
|
c.
|
Review and approve compensation arrangements for new executive officers and termination arrangements for executive officers.
|
|
4.
|
General Compensation Oversight. Monitor and evaluate matters relating to the compensation and benefits structure of the Company as the Committee deems appropriate, including:
|
|
a.
|
Provide guidance to management on significant issues affecting compensation philosophy or policy.
|
|
b.
|
Provide input to management on whether compensation arrangements for Company executives incentivize unnecessary and excessive risk taking.
|
|
c.
|
Review and approve policies regarding CEO and other executive officer compensation.
|
|
5.
|
Equity and Other Benefit Plan Oversight.
|
|
a.
|
Serve as the committee established to administer the Company’s equity-based and employee benefit plans and perform the duties of the committee under those plans. The Compensation Committee may delegate those responsibilities to senior management as it deems appropriate as limited by the plans.
|
|
b.
|
Appoint and remove plan administrators for the Company’s retirement plans for the Company’s employees and perform other duties that the Board may have with respect to the Company’s retirement plans.
|
|
6.
|
Compensation Consultant Oversight.
|
|
a.
|
Retain and terminate compensation consultants that advise the Committee, as it deems appropriate, including approval of the consultants’ fees and other retention terms and ensure that the compensation consultant retained by the Committee is independent of the Company.
|
The Compensation Committee may form and
delegate authority to subcommittees and may delegate authority to one or more designated members of the committee. The Committee
may delegate to the Chief Executive Officer authority to make grants of equity-based compensation in the form of rights or options
to eligible officers and employees who are not executive officers, such authority including the power to (i) designate officers
and employees of the Company or any of its subsidiaries to be recipients of such rights or options created by the Company,
and (ii) determine the number of such rights or options to be received by such officers and employees; provided, however, that
the resolution so authorizing the Chief Executive Officer shall specify the total number of rights or options the Chief Executive
Officer may so award. If such authority is delegated, the Chief Executive Officer shall regularly report to the Committee
grants so made. The Committee may revoke any delegation of authority at any time. The Compensation Committee has not
delegated any authority to the Chief Executive Officer.
For purposes of determining CEO compensation
for 2014, 2015, and 2016, the Compensation Committee engaged a compensation consultant, Compensation Resources Inc., to conduct
studies of the competitive levels of compensation for comparable positions among similar publicly traded companies. The Compensation
Committee did not use a compensation consultant in connection with 2017, 2018 and 2019 CEO compensation.
A copy of the compensation committee charter
is available at www.appliedminerals.com.
Compensation Committee Interlocks and
Insider Participation
None of the members of the Compensation
Committee (Messrs. Betz, Levy and Scott) are or were officers or employees of the Company and none (and none of the members of
their immediate families) had in 2018 and 2019 any relationships of the type described in Item 404 of Regulation S-K. There have
not been any interlocking relationships of the type described in Item 407(e)(4)(iii) of Regulation S-K. Messrs. Concha and Carney
participated in deliberations of the Board of Directors concerning executive officer compensation other than his own.
Stockholder Communications to the Board of Directors
Stockholders may communicate with the Board
of Directors by sending an email or a letter to Applied Minerals, Inc. Board of Directors, c/o President, PO Box 432, Eureka, UT
84628. The President will receive the correspondence and forward it to the individual director or directors to whom the communication
is directed or to all directors if not directed to one or more specifically.
Part 3 Information concerning Executive Officers and Their
Compensation
Named Executive Officers
The Named Executive Officers of the Company are:
Name
|
|
Age
|
|
Position
|
|
|
|
|
|
Christopher T. Carney
|
|
50
|
|
President and Chief Executive Officer, Chief Financial Officer, Secretary and
Director
|
Christopher
T. Carney From February 2009 through May 2012, Mr. Carney was the Interim Chief Financial Officer of the Company.
From May 2012 through August 2015, Mr. Carney was a VP of Business Development for the Company. Mr. Carney was appointed Chief
Financial Officer of the Company in August 2015 when the previous Chief Financial Officer resigned. Mr. Carney was appointed Secretary
in September 2019 and Chief Executive Officer on October 22, 2020 upon Mr. Concha’s resignation. From March 2007 until December
2008, Mr. Carney was an analyst at SAC Capital/CR Intrinsic Investors, LLC, a hedge fund, where he evaluated the debt and equity
securities of companies undergoing financial restructurings and/or operational turnarounds. From March 2004 until October 2006,
Mr. Carney was a distressed debt and special situations analyst for RBC Dain Rauscher Inc., a registered broker-dealer. Mr. Carney
graduated with a BA in Computer Science from Lehman College and an MBA in Finance from Tulane University.
All officers serve at the pleasure of the Board.
SUMMARY COMPENSATION TABLE
Name and
Principal
Position
|
|
Year
|
|
|
Salary ($)
|
|
|
Cash
Bonus
($)
|
|
|
Option
Award
($) (1)
|
|
|
Total ($)
|
|
Andre Zeitoun (2)
|
|
2019
|
|
|
|
242,083
|
|
|
|
- 0 -
|
|
|
|
- 0 -
|
|
|
|
242,083
|
|
|
|
2018
|
|
|
|
350,000
|
|
|
|
75,000
|
(8)
|
|
|
- 0 -
|
|
|
|
425,000
|
|
|
|
2017
|
|
|
|
350,000
|
|
|
|
270,000
|
(3)(4)
|
|
|
614,596
|
(5)
|
|
|
1,234,596
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Christopher T. Carney (6)
|
|
2019
|
|
|
|
200,000
|
|
|
|
- 0 -
|
|
|
|
- 0 -
|
|
|
|
200,000
|
|
|
|
2018
|
|
|
|
200,000
|
|
|
|
20,000
|
(8)
|
|
|
- 0 -
|
|
|
|
220,000
|
|
|
|
2017
|
|
|
|
135,000
|
(6)
|
|
|
30,000
|
(4)
|
|
|
246,676
|
(6)(7)
|
|
|
411,676
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
William Gleeson (2)
|
|
2019
|
|
|
|
250,000
|
|
|
|
- 0 -
|
|
|
|
- 0 -
|
|
|
|
250,000
|
|
|
|
2018
|
|
|
|
250,000
|
|
|
|
20,000
|
(8)
|
|
|
- 0 -
|
|
|
|
270,000
|
|
|
|
2017
|
|
|
|
250,000
|
|
|
|
30,000
|
(4)
|
|
|
193,471
|
(7)
|
|
|
473,471
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mario Concha (9)
|
|
2019
|
|
|
|
61,667
|
|
|
|
- 0 -
|
|
|
|
- 0 -
|
|
|
|
61,667
|
|
|
|
2018
|
|
|
|
- 0 -
|
|
|
|
- 0 -
|
|
|
|
- 0 -
|
|
|
|
- 0 -
|
|
|
|
2017
|
|
|
|
- 0 -
|
|
|
|
- 0 -
|
|
|
|
- 0 -
|
|
|
|
- 0 -
|
|
(1)
|
Pursuant to SEC rules, the amounts shown exclude the impact of estimated forfeitures related to service-based vesting conditions. For additional information, refer to Note 10 to the Notes to Consolidated Financial Statements in the Company’s Annual Report on Form 10-K. These amounts reflect the Company’s accounting expense for these awards, and do not correspond to the amount that will be recognized as income by the named executive officers o the amount that will be recognized as a tax deduction by the Company, if any, upon exercise. The options awards were valued using the Black Scholes Option Valuation Model.
|
|
|
(2)
|
Mr. Zeitoun resigned as President and CEO
on September 9, 2019. Mr. Gleeson resigned as General Counsel on April 5, 2020.
|
|
|
(3)
|
Mr. Zeitoun’s revenue-related bonus for 2017 was 4% of the first $4 million in revenues up to a bonus of $150,000.
|
|
|
(4)
|
On December 7, 2017, the Board of Directors, on the
recommendation of the Compensation Committee, granted to Mr. Zeitoun a bonus for service in 2017 of $120,000, and in
particular for work on amendments to the Series A and Series 2023 Notes and the BASF supply and tolling agreements, and to
each of Mr. Carney and Mr. Gleeson a bonus for service in 2017, The bonuses were paid in 2018. Mr. Carney was appointed President and CEO on October 22, 2020.
|
(5)
|
In December 2017, the Board of Directors granted Mr. Zeitoun options to purchase a time when the market price for the common stock was $.04 per share. The options vest based upon certain performance goals being met by management. During December options to purchase 5,955,386 shares of common stock vested. The Black Scholes value of the options at August 18, 2017 was $297,800.
|
(6)
|
Mr. Carney’s salary was at a rate of $150,000 per annum for the first 7.5 months of 2017 and then was to increase to a rate of $200,000 per annum for the remaining 4.5 months of 2017. His salary was not increased to a rate of $200,000 per year and Mr. Carney is owed $18,765 in respect thereof relating to 2017. In lieu of a $50,000 salary reduction for twelve months beginning August 16, 2016, Mr. Carney received three-year options to purchase common stock with a Black Scholes value of $40,500. During the first 7.5 months of 2017, $23,625 of the Black Scholes value of the options vested.
|
|
|
(7)
|
In December 2017, the Board of Directors granted to Mr. Carney and Mr. Gleeson options to purchase 4,780,550 shares of common stock and 3,749,440 shares of common stock, respectively, at $0.06 per share. The options would vest based upon certain performance goals being met by management. During December 2017, options to purchase 2,390,275 shares of stock by Mr. Carney and options to purchase 1,874,720 shares of common stock by Mr. Gleeson vested. The Black Scholes values of the options to purchase common stock by Mr. Carney and Mr. Gleeson were $223,495 and $175,290, respectively.
|
|
|
(8)
|
On January 2019, the Board of Directors, on the recommendation of the Compensation Committee, granted to Mr. Zeitoun, Mr. Carney and Mr. Gleeson bonuses for service in 2018 of $75,000, $20,000 and $20,000, respectively. The performances were based on performance in 2018.
|
|
|
(9)
|
Mr. Concha was appointed President and CEO on September 9, 2019. The Compensation Committee
set Mr. Concha’s salary at $200,000 per annum. Mr. Concha resigned as President and CEO on October 22, 2020.
|
Pensions
The Company does not have any pension plan
or any nonqualified defined contribution or any nonqualified deferred compensation plans.
Potential Payments on Termination or Change in Control
Mr. Carney. In the event Mr.
Carney was terminated by the Company without Cause or he terminated his employment for Good Reason, he would receive (i) not
less than two months of his base salary and (ii) continuation of benefits on the same terms as in effect immediately prior to the
date of termination for a period of two months. Mr. Carney's base salary was $200,000.
Plan-Based Awards
The following table lists the plan-based
awards granted under the 2017 Incentive Plan.
Name
|
|
Grant date
|
|
|
All other
option awards:
Number of
securities
underlying
options
(#)
|
|
|
Exercise
price
of option
awards
($/Share)
|
|
|
Grant date
fair value of
stock and
option
awards
($)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Andre Zeitoun
|
|
|
8-18-17
|
|
|
|
11,910,772
|
|
|
|
0.06
|
|
|
|
614,596
|
|
Christopher T. Carney
|
|
|
8-18-17
|
|
|
|
4,780,550
|
|
|
|
0.06
|
|
|
|
246,676
|
|
William Gleeson
|
|
|
8-18-17
|
|
|
|
3,748,939
|
|
|
|
0.06
|
|
|
|
193,471
|
|
Mario Concha
|
|
|
8-18-17
|
|
|
|
3,666,667
|
|
|
|
0.06
|
|
|
|
189,225
|
|
Outstanding Equity Awards at December
31, 2019
The following table provides information
on the holdings as of December 31, 2019 of stock options granted to the named executive officers. This table includes unexercised
and unvested option awards. Each equity grant is shown separately for each named executive officer
OUTSTANDING EQUITY AWARDS AT DECEMBER
31, 2017
Name
|
|
Grant
Date
|
|
Number of
Securities
Underlying
Unexercised
Options:
Exercisable
|
|
|
Number of
Securities
Underlying
Unexercised
Options:
Unexercisable
|
|
|
Equity
Incentive
Plan
Awards
Number of
Securities
Underlying
Unexercised
Unearned
Options
|
|
|
Option
Exercise
Price
|
|
|
Option
Expiration
Date
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Andre Zeitoun (1)
|
|
02-08-11
|
|
|
1,742,792
|
|
|
|
—
|
|
|
|
—
|
|
|
$
|
0.83
|
|
|
01-01-22
|
|
|
11-20-12
|
|
|
1,742,792
|
|
|
|
—
|
|
|
|
—
|
|
|
$
|
1.66
|
|
|
01-01-23
|
|
|
05-11-16
|
|
|
321,123
|
|
|
|
—
|
|
|
|
—
|
|
|
$
|
0.24
|
|
|
05-11-21
|
|
|
12-14-17
|
|
|
8,933,079
|
|
|
|
2,977,693
|
|
|
|
—
|
|
|
$
|
0.06
|
|
|
12-13-27
|
Christopher T. Carney
|
|
02-08-11
|
|
|
580,930
|
|
|
|
—
|
|
|
|
—
|
|
|
$
|
0.83
|
|
|
01-01-22
|
|
|
11-20-12
|
|
|
580,931
|
|
|
|
—
|
|
|
|
—
|
|
|
$
|
1.66
|
|
|
01-01-23
|
|
|
06-10-14
|
|
|
75,000
|
|
|
|
—
|
|
|
|
—
|
|
|
$
|
0.84
|
|
|
06-10-24
|
|
|
02-05-15
|
|
|
48,611
|
|
|
|
1,389
|
|
|
|
—
|
|
|
$
|
0.68
|
|
|
02-05-25
|
|
|
05-11-16
|
|
|
248,344
|
|
|
|
—
|
|
|
|
—
|
|
|
$
|
0.24
|
|
|
05-11-21
|
|
|
07-06-16
|
|
|
500,000
|
|
|
|
—
|
|
|
|
—
|
|
|
$
|
0.16
|
|
|
08-15-19
|
|
|
12-14-17
|
|
|
3,585,413
|
|
|
|
1,195,137
|
|
|
|
—
|
|
|
$
|
0.06
|
|
|
12-13-27
|
William Gleeson (2)
|
|
08-18-11
|
|
|
900,000
|
|
|
|
—
|
|
|
|
—
|
|
|
$
|
1.90
|
|
|
08-18-21
|
|
|
11-20-12
|
|
|
72,406
|
|
|
|
—
|
|
|
|
—
|
|
|
$
|
1.66
|
|
|
11-20-22
|
|
|
06-10-14
|
|
|
600,000
|
|
|
|
—
|
|
|
|
—
|
|
|
$
|
0.84
|
|
|
06-10-24
|
|
|
05-11-16
|
|
|
248,344
|
|
|
|
—
|
|
|
|
—
|
|
|
$
|
0.24
|
|
|
05-11-21
|
|
|
12-14-17
|
|
|
2,812,080
|
|
|
|
937,360
|
|
|
|
—
|
|
|
$
|
0.06
|
|
|
12-13-27
|
Mario Concha (3)
|
|
03-14-14
|
|
|
50,000
|
|
|
|
—
|
|
|
|
—
|
|
|
$
|
0.83
|
|
|
03-13-24
|
|
|
02-12-15
|
|
|
50,000
|
|
|
|
—
|
|
|
|
—
|
|
|
$
|
0.66
|
|
|
02-12-25
|
|
|
01-01-16
|
|
|
50,000
|
|
|
|
—
|
|
|
|
—
|
|
|
$
|
0.28
|
|
|
01-01-26
|
|
|
01-06-16
|
|
|
43,885
|
|
|
|
—
|
|
|
|
—
|
|
|
$
|
0.29
|
|
|
01-06-21
|
|
|
01-29-16
|
|
|
80,000
|
|
|
|
—
|
|
|
|
—
|
|
|
$
|
0.28
|
|
|
01-29-21
|
|
|
05-11-16
|
|
|
200.000
|
|
|
|
—
|
|
|
|
—
|
|
|
$
|
0.25
|
|
|
05-11-21
|
|
|
05-11-16
|
|
|
430,000
|
|
|
|
—
|
|
|
|
—
|
|
|
$
|
0.25
|
|
|
05-11-21
|
|
|
08-01-16
|
|
|
70,000
|
|
|
|
—
|
|
|
|
—
|
|
|
$
|
0.25
|
|
|
08-01-26
|
|
|
05-23-17
|
|
|
70,000
|
|
|
|
—
|
|
|
|
—
|
|
|
$
|
0.25
|
|
|
05-17-22
|
|
|
05-24-17
|
|
|
70,000
|
|
|
|
—
|
|
|
|
—
|
|
|
$
|
0.25
|
|
|
05-24-22
|
|
|
12-07-17
|
|
|
140,000
|
|
|
|
—
|
|
|
|
—
|
|
|
$
|
0.25
|
|
|
12-07-22
|
|
|
08-08-17
|
|
|
3,666,667
|
|
|
|
—
|
|
|
|
—
|
|
|
$
|
0.06
|
|
|
08-08-27
|
|
|
04-25-19
|
|
|
500,000
|
|
|
|
—
|
|
|
|
—
|
|
|
$
|
0.04
|
|
|
04-25-29
|
|
(1)
|
Mr. Zeitoun resigned as President and Chief Executive Officer on September 9, 2019
|
|
(2)
|
Mr. Gleeson resigned as General Counsel on April 5, 2020.
|
|
(3)
|
Mr. Concha was appointed President and CEO on September 9, 2019 and resigned as President and CEO on October 22,
2020.
|
Options Exercised and Stock Vested
None of the Named Executive Officers has
exercised any options, SARs or similar instruments and none had any stock awards, vested or unvested.
Nonqualified Defined Contribution and Other Nonqualified
Deferred Compensation Plans
There are no nonqualified defined contribution
and nonqualified deferred compensation plans for Named Executive Officers.
Part 4 Compensation Discussion and Analysis
Objectives and Strategy
The Company’s objectives are to develop
a range of commercial applications for its halloysite clay-based and iron oxide-based products and to market those applications
to industries seeking enhanced product functionality and to market its iron oxides for pigment and other uses. We believe the successful
marketing of such applications will generate material profits for the Company, which, in turn, will create significant value for
its stockholders. To realize this objective, the Company must attract and retain individuals, including our Named Executive Officers
(“Named Executive Officers” or “NEOs”) (Messrs. Zeitoun, Carney and Gleeson), who possess
the skill sets and experience needed to effectively develop and implement the business strategies and corporate governance infrastructure
necessary to achieve commercial success.
Accordingly, compensation for the Named Executive Officers is
designed to:
|
●
|
Attract, motivate, and retain qualified Named Executive Officers;
|
|
●
|
Incentivize the Named Executive Officers to lead the Company to profitable operations and to increase stockholder value;
|
|
●
|
Assure that over time a significant part of NEO compensation is linked to the Company’s long-term stock price performance, which aligns the Named Executive Officers’ financial interests with those of the Company’s stockholders
|
|
●
|
Motivate the Named Executive Officers to develop long-term careers at the Company and to contribute to its future prospects; and
|
|
●
|
Permit the Named Executive Officers to remain focused on the development of the Company’s business in the midst of actual or potential change-in-control transactions.
|
The Company does not have a policy concerning
minimum ownership or hedging by officers of Company securities.
Compensation of Mr. Zeitoun
Mr. Zeitoun was named president and CEO of the Company in January
2009 and resigned on September 9, 2019.
2017 Compensation
On March 8, 2017, the Board determined
that Mr. Zeitoun’s 2017 compensation is as follows: salary — $350,000; cash receipts bonus — 4% of monthly gross
cash receipts, up to a maximum bonus of $150,000; revenue bonus — $100,000 if GAAP revenue exceeded $6 million; cash flow
bonus — $100,000 if the Company is cash flow positive for 2017. The cash receipts bonus was earned. The revenue and cash
flow bonuses were not earned.
On August 18, 2017, options to purchase
11,910,772 shares of common stock were issued to Mr. Zeitoun. The options are ten-year options and the exercise price is $0.06.
Vesting conditions are as follows:
|
●
|
25% of the options would vest upon the closing of the sale of an aggregate of $600,000 of units (consisting of a share of Common Stock and a warrant to buy .25 of a share of Common Stock) at $0.04 per unit. This vesting condition has been satisfied.
|
|
●
|
25% of the options would vest upon the receipt of at least $900,000 from one or more of the following sources: sale(s) of Common Stock over and above $600,000, consideration for entering into licensing or similar agreement(s), and/or consideration for entering into agreement(s) relating to the sale or lease of minerals rights or entering into options or other agreements relating mineral rights..
|
|
●
|
25% of the options would vest when the Company has toll processing arrangements with two toll processors of halloysite that, in management’s good faith belief, can process halloysite to the Company’s specifications. One of the agreements may be a back-up or standby arrangement.
|
|
●
|
8.3% of the options if EBITDA is positive over a period of twelve months.
|
|
●
|
8.3% of the options if EBITDA equals or exceeds $2 million over a period of twelve months.
|
The first three conditions were satisfied in 2017.
On December 7, 2017, the Board of Directors,
on the recommendation of the Compensation Committee, granted to Mr. Zeitoun a bonus for service in 2017, and in particular for
work on amendments to the Series A and Series 2023 Notes and the BASF supply and tolling agreements, of $120,000. The bonus was
payable in six monthly installments beginning in January, 2018 to the extent that in the judgment of the audit committee there
is sufficient cash available for other corporate purposes. The bonus was fully paid as of June 29, 2018.
2018 Compensation
On the recommendation of the Compensation
Committee, the Board determined Mr. Zeitoun’s 2018 compensation to be as follows. salary — $350,000. bonus —
$75,000. The bonus was paid in 2019.
In reaching its decisions, the Compensation
Committee and the Board took into account (i) the results of the most recent the Say-on-Pay vote (93%%) in favor, which suggested
that stockholders were generally favorable to the compensation scheme, (ii) the Company’s financial results and prospects
for generating revenues and the need to conserve capital, which led to no increase in salary and the elimination of the 4% bonus,
(iii) Mr. Zeitoun’s efforts in connection of the amendment of Series A and the Series 2023 notes and the sale of the waste
piles for $4.5 million, which led to the bonus and (iv) the options granted in 2017, which provided sufficient lion-term incentive,
so that no more long-term incentive was deemed necessary.
The Compensation Committee did not use
a compensation consultant.
2019 Compensation
On the recommendation of the Compensation
Committee, the Board determined Mr. Zeitoun’s 2019 compensation to be as follows. salary — $350,000. No bonus was granted
to Mr. Zeitoun.
In reaching its decisions, the Compensation
Committee and the Board took into account (i) the results of the most recent the Say-on-Pay vote (81% approval), which suggested
that stockholders were generally favorable to the compensation scheme, (ii) the Company’s financial results and prospects
for generating revenues and the need to conserve capital and (iii) the options granted to Mr. Zeitoun in 2017, which provided sufficient
lion-term incentive so that no more long-term incentive was deemed necessary.
The Compensation
Committee did not use a compensation consultant.
Compensation for Messrs. Gleeson
and Carney
2017 Compensation
In December, 2016, the Board on the recommendation
of the Compensation Committee, determined as follows:
|
a.
|
Mr. Carney’s 2017 compensation
was as follows: salary — $150,000 per annum through August 15, 2017 and $200,000 per annum thereafter; revenue bonus —
$25,000 if GAAP revenue exceeds $6 million; cash flow bonus — $25,000 if the Company is cash flow positive for 2017. The
bonuses were not paid.
|
|
b.
|
Mr. Gleeson’s 2017 compensation
was as follows: salary — $250,000; revenue bonus — $25,000 if GAAP revenue exceeds $6 million; cash flow bonus —
$25,000 if the Company is cash flow positive for 2017.
|
None of the bonuses were earned or paid.
On August 18, 2017, 4,780,550 options to
purchase Common Stock were granted to Mr. Carney and 3,748,439 options were granted to Mr. Gleeson. The vesting conditions and
the relevant definitions are the same as vesting conditions and definitions described above relating to the options granted to
Mr. Zeitoun on August 18, 2017.
On December 7, 2017, the Board of Directors,
on the recommendation of the Compensation Committee, granted to each of Mr. Carney and Mr. Gleeson a bonus for service, in particular
for work on amendments to the Series A and Series 2023 Notes and the BASF supply and tolling agreements, in 2017 of $30,000.
The bonuses were payable to the extent that in the judgment of the audit committee there is sufficient cash available for other
corporate purposes. The bonuses have been paid.
2018 Compensation
On the recommendation of the Compensation
Committee, the Board determined 2018 compensation to be as follows: Mr. Carney: salary — $200,000; bonus — $20,000.
The bonus was determined on January 31, 2019. Mr. Gleeson: salary — $250,000; bonus — $20,000. The bonus was determined
on January 31, 2019.
In reaching its decisions, the Compensation
Committee and the Board took into account (i) the results of the most recent the Say-on-Pay vote (93%) in favor, which suggested
that stockholders were generally favorable to the compensation scheme, (ii) the Company’s financial results and prospects
for generating revenues and the need to conserve capital, which led to no increase in salary, (iii) their efforts in connection
of the amendment of Series A and the Series 2023 notes and the sale of the waste piles for $4.5 million, which led to the bonus
and (iv) the options granted in 2017, which provided sufficient lion-term incentive, so that no more long-term incentive was deemed
necessary.
The Compensation Committee did not use
a compensation consultant.
2019 Compensation
On the recommendation of the Compensation
Committee, the Board determined 2019 compensation to be as follows: Mr. Carney: salary — $200,000. Mr. Gleeson: salary —
$250,000. No bonus was granted to either executive.
In reaching its decisions, the Compensation Committee and the
Board took into account (i) the results of the most recent the Say-on-Pay vote (81%) in favor, which suggested that stockholders
were generally favorable to the compensation scheme, (ii) the Company’s financial results and prospects for generating revenues
and the need to conserve capital, which led to no increase in salary and (iii) the options granted in 2017, which provided sufficient
lion-term incentive, so that no more long-term incentive was deemed necessary.
The Compensation Committee did
not use a compensation consultant.
Compensation for Mr. Concha
2019 Compensation
On the recommendation of the Compensation Committee, the Board
determined Mr. Concha’s 2019 compensation to be as follows. salary — $200,000.
The Compensation Committee did
not use a compensation consultant.
Tax and Accounting Treatment of Compensation
The Compensation Committee is aware that
Section 162(m) of the Internal Revenue Code treats certain elements of executive compensation in excess of $1 million a year as
an expense not deductible by the Company for federal income tax purposes. Depending on the market price of the Company’s
common stock on the date of exercise of options that are not performance-based, the compensation of certain executive officers
in future years may be in excess of $1 million for purposes of Section 162(m). The Compensation Committee reserves the right to
pay compensation that may be non-deductible to the Company if it determines that it would be in the best interests of the Company.
Tax and Accounting Treatment of Options
We are required to recognize in our financial
statements compensation costs arising from the issuance of stock options. GAAP requires that such that compensation cost is determined
using fair value principles (we use the Black-Scholes method of valuation) and is recognized in our financial statements over the
requisite service period of an instrument. However, the tax deduction is only recorded on our tax return when the option is exercised.
The tax benefit received at exercise and recognized in our tax return is generally equal to the intrinsic value of the option on
the date of exercise.
Compensation Policies and Practices
as They Relate to Risk Management
The Company does not believe that
its compensation policies and practices are reasonably likely to have a material adverse effect on the Company as they relate
to risk management practices and risk-taking incentives
Compensation Committee Report
The Compensation Committee has reviewed and discussed
the Compensation Discussion and Analysis with management. Based on such review and discussions, the Compensation Committee recommended
to the Board that the Compensation Discussion and Analysis be included in the Annual Report on Form 10-K and the proxy statement.
John Levy
Robert Betz
Geoffrey Scott
Part 5 Information concerning Independent
Registered Public Accountant
Independent Registered Accountant for 2019
MaloneBailey LLP (“MaloneBailey”)
was selected by our Board of Directors as the Company’s independent registered public accounting firm for the years
ending December 31, 2019 and as our independent registered public accounting firm reviewed the interim financial statements for
the three and nine months ended September 30, 2019.
The Board has selected MaloneBailey
as the Company’ independent registered public accounting firm for the year ended December 31, 2020. The Board asks
stockholders to ratify that selection. Although current law, rules, and regulations require the Board of Directors to engage
and retain the Company’s independent auditor, the Board considers the selection of the independent auditor to be an
important matter of stockholder concern and is submitting the selection of MaloneBailey LLP for ratification by stockholders
as a matter of good corporate practice.
The affirmative vote of holders of a majority
of the shares of Common Stock cast in person or by proxy at the meeting is required to approve the ratification of the selection
of MaloneBailey LLP as the Company’s independent auditor for the current fiscal year. If a majority of votes cast does not
ratify the selection of MaloneBailey LLP, the Board of Directors will consider the result a recommendation to consider the selection
of a different firm. Representatives of the MaloneBailey LLP are expected to be present at the Annual Meeting, will
have the opportunity to make a statement if they desire to do so, and such representatives are expected to be available to respond
to appropriate questions.
EisnerAmper LLP (“EisnerAmper”),
the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2016 and December 31,
2017, was dismissed on October 4, 2018. The dismissal was approved by the Company’s Audit Committee.
Fees to Accountants
MaloneBailey LLP (“MaloneBailey”)
was selected by our Board of Directors as the Company’s independent registered public accounting firm for the years
ending December 31, 2018 and 2019 and as our independent registered public accounting firm reviewed the interim financial statements
for the three and nine months ended September 30, 2018 and 2019.
EisnerAmper LLP (“EisnerAmper”),
the Company’s independent registered public accounting firm for the fiscal years ending December 31, 2016 and December 31,
2017, was dismissed on October 4, 2018. The dismissal was approved by the Company’s Audit Committee.
EisnerAmper’s reports on the financial
statements for 2016 and 2017 did not contain an adverse opinion or a disclaimer of opinion, and was not qualified or modified as
to audit scope or accounting principles. EisnerAmper’s report includes an explanatory paragraph about the existence of substantial
doubt concerning the Company’s ability to continue as a going concern.
There were no disagreements with EisnerAmper
on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreement(s),
if not resolved to the satisfaction of EisnerAmper, would have caused it to make reference to the subject matter of the disagreement(s)
in connection with its report on the financial statements for the years ended December 31, 2016 or December 31, 2017.
The following table presents fees for services
rendered by EisnerAmper for the period including January 1, 2018 through October 4, 2018 and the year ended December 31, 2017,
respectively.
|
|
January 1, 2018
through October
4, 2018
|
|
|
December 31,
2017
|
|
|
|
|
|
|
|
|
Audit Related Fees (1)
|
|
$
|
160,157
|
|
|
$
|
143,500
|
|
Tax Fees
|
|
|
7,500
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
167,657
|
|
|
$
|
158,500
|
|
|
(1)
|
Audit fees represent the aggregate
fees paid for professional services including: (i) audit, (ii) S-1 filings and (iii) SEC comment letters.
|
The following table presents fees for services rendered by MaloneBailey,
the independent auditor for the audit of the Company’s annual consolidated financial statements for the year ended December
31, 2019 and the period including October 4, 2018 through December 31, 2018.
|
|
January 1, 2019
through
December 31,
2019
|
|
|
October 4, 2018
through
December 31,
2018
|
|
|
|
|
|
|
|
|
Audit Related Fees (1)
|
|
$
|
97,500
|
|
|
$
|
67,500
|
|
Tax Fees
|
|
|
6,500
|
|
|
|
- 0 -
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
104,000
|
|
|
$
|
67,500
|
|
(1)
|
Audit fees represent the aggregate fees paid for professional services including: (i) audit, (ii) S-1 filings and (iii) SEC comment letters.
|
The audit reports of EisnerAmper on the
financial statements of the Company as of and for the years ended December 31, 2017 and 2016 contained no adverse opinion
or disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope or accounting principle except, the
audit reports for the years ended December 31, 2017 and 2016 include an explanatory paragraph about the existence of substantial
doubt concerning the Company's ability to continue as a going concern.
During the years ended December 31,
2017 and 2016 and the interim period from January 1, 2018 through October 4, 2018, the Company had no disagreements with EisnerAmper
on any matter of accounting principles or practices, financial statement disclosure or auditing scope or procedure, which disagreements,
if not resolved to the satisfaction of EisnerAmper, would have caused them to make reference to the subject matter of the disagreement(s) in
connection with its reports on the financial statements for such years. During the years ended December 31, 2017 and 2016
and the interim period from January 1, 2018 through October 4, 2018, there were no “reportable events,” as that
term is described in Item 304(a)(1)(v) of Regulation S-K, except as described herein. In Part I, Item
4 of the Company’s quarterly report on Form 10-Q for the fiscal quarter ended June 30, 2018, as filed with the Securities
and Exchange Commission (the “SEC”) on August 20, 2018 (the “Second Quarter 2018 Form 10-Q”), management
of the Company reported on its evaluation of the effectiveness of the Company’s disclosure controls and procedures (as defined
in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) as of June 30, 2018, the end of the
period covered by the Second Quarter 2018 Form 10-Q. The Second Quarter 2018 Form 10-Q stated that, based on such evaluation,
the Company’s Chief Executive Officer (principal executive officer) and the Company’s Chief Financial Officer (principal
financial officer) concluded that the Company’s disclosure controls and procedures were not effective because of the material
weaknesses in the Company’s internal control over financial reporting described in Part II, Item 9A of the Company’s
Form 10-K as of December 31, 2017, which was filed with the SEC on April 17, 2018 (the “2018 Form 10-K”).
Management identified the following material
weaknesses as of December 31, 2017 as reported in the 2018 Form 10-K, which were still applicable as of September 30,
2020, and caused management to conclude that as of December 31, 2017, their internal controls over financial reporting were not
effective at the reasonable assurance level:
|
●
|
Insufficient segregation of
duties, oversight of work performed and lack of compensating controls in the Company’s finance and accounting functions
due to limited personnel; and
|
|
●
|
The Company lacks a sufficient process for periodic financial reporting, including timely preparation and review of financial reports and statements.
|
Because of the material weaknesses described
in the 2018 Form 10-K, the Company’s Chief Executive Officer (principal executive officer) and Chief Financial Officer
(principal financial officer) concluded that the Company did not maintain effective internal control over financial reporting as
of December 31, 2017, based on criteria in Internal Control-Integrated Framework (2013) issued by the Committee of Sponsoring
Organizations of the Treadway Commission.
During the fiscal years ended December 31, 2017 and 2016
and the interim period from January 1, 2018 through October 4, 2018, neither the Company, nor anyone on its behalf, consulted
Malone Bailey regarding either (i) the application of accounting principles to a specified transaction, either completed or
proposed, or the type of audit opinion that might be rendered on the financial statements of the Company and no written report
or oral advice was provided to the Company that Malone Bailey concluded was an important factor considered by the Company in reaching
a decision as to any accounting, auditing or financial reporting issue; or (ii) any matter that was either the subject of
a “disagreement” (as defined in Item 304(a)(1)(iv) of Regulation S-K and the related instructions) or a “reportable
event” (as that term is defined in Item 304(a)(1)(v) of Regulation S-K).
Policy on Board of Directors' Pre-Approval of Audit an Non-Audit
Services of Independent Auditors
The Audit Committee has adopted a policy
for the pre-approval of all audit, audit-related, tax, and other services provided by the Company’s independent registered
public accounting firm. The policy is designed to ensure that the provision of these services does not impair the registered public
accounting firm’s independence. Under the policy, any services provided by the independent registered public accounting firm,
including audit, audit-related, tax and other services must be specifically pre-approved by the Board of Directors. The Board of
Directors does not delegate responsibilities to pre-approve services performed by the independent registered public accounting
firm to management. For the fiscal year ended December 31, 2019, all services provided by the Company’s independent registered
public accounting firm were pre-approved by the Board of Directors.
Part 6 Additional Important Information
Beneficial Stock Ownership: Directors, Named Executive
Officers, and 5% Holders.
The following table sets forth, as of November 9, 2020, information
regarding the beneficial ownership of our common stock with respect to each of the named executive officers, each of our directors,
each person known by us to own beneficially more than 5% of the common stock, and all of our directors and executive officers as
a group. Each individual or entity named has sole investment and voting power with respect to shares of common stock indicated
as beneficially owned by such person, subject to community property laws, where applicable, except where otherwise noted. The percentage
of common stock beneficially owned is based on 175,513,549 shares of common stock outstanding as of November 9, 2020 plus the shares
that a person has a right to acquire within 60 days of November 9, 2020.
|
|
Number of
Shares of
|
|
|
Percentage
of Common
|
|
|
|
Common Stock
Beneficially
|
|
|
Stock
Beneficially
|
|
Name and Address (1)
|
|
Owned (2)
|
|
|
Owned
|
|
Mario Concha (3) (4)
|
|
|
8,569,884
|
|
|
|
4.7
|
|
Robert Betz (3) (5)
|
|
|
4,140,404
|
|
|
|
2.3
|
|
John Levy (3) (6)
|
|
|
3,260,801
|
|
|
|
1.8
|
|
Geoffrey Scott (3) (7)
|
|
|
9,285,210
|
|
|
|
5.3
|
|
Christopher T. Carney (8) (14)
|
|
|
6,402,104
|
|
|
|
3.5
|
|
All Officers and Directors as a Group
|
|
|
31,658,403
|
|
|
|
16.2
|
|
IBS Capital, LLC (9)
|
|
|
36,780,092
|
|
|
|
19.5
|
|
Samlyn Capital, LLC (10)
|
|
|
51,191,163
|
|
|
|
23.6
|
|
Berylson Master Fund, L.P. (11)
|
|
|
15,395,594
|
|
|
|
8.2
|
|
James Berylson (11)
|
|
|
16,668,594
|
|
|
|
8.8
|
|
Kingdon Capital Management, LLC (12)
|
|
|
20,582,381
|
|
|
|
10.5
|
|
Masato Katayama (13)
|
|
|
16,834,335
|
|
|
|
9.5
|
|
(1)
|
Unless otherwise indicated, the address of the persons named in this column is c/o Applied Minerals, Inc., P.O. Box 432, Eureka, UT 84628
|
(2)
|
Included in this calculation are shares deemed beneficially owned by virtue of the individual’s right to acquire them within 60 days of the date of November 9, 2020 as determined pursuant to Rule 13d-3 of the Securities Exchange Act of 1934.
|
(3)
|
Director
|
(4)
|
Mr. Concha’s holdings include: (i) options to purchase 50,000 shares of common stock at $0.83 per share expiring in March, 2024; (ii) options to purchase 50,000 shares of common stock at $0.66 per share expiring in February, 2025; (iii) options to purchase 50,000 shares of common stock at $0.28 per share expiring in January, 2026; (iv) options to purchase 43,885 shares of common stock at $0.285 per share expiring in January, 2021; (v) options to purchase 30,000 shares of common stock at $0.25 per share and expiring in May, 2021; options to purchase 600,000 shares of common stock at $0.25 expiring in May, 2021; (vi) options to purchase 70,000 shares of common stock expiring in August, 2026; (vii) options to purchase 140,000 shares of common stock at $0.70 expiring in May, 2022; (viii) options to purchase 3,666,667 shares of common stock expiring at $0.06 in August 2027; (ix) options to purchase 140,000 shares of common stock expiring in December, 2022; (x) options to purchase 500,000 shares of common stock at $0.04 expiring in April, 2029; and (xi) June 2018 Warrants to purchase 1,000,000 shares of common stock at $0.15 per share expiring in June, 2021.
|
(5)
|
Mr. Betz’s holdings include: (i) options to purchase 50,000 shares of common stock at $0.83 per share expiring in March, 2024; (ii) options to purchase 50,000 shares of common stock at $0.66 per share expiring in February 2025; (iii) options to purchase 50,000 shares of common stock at $0.28 per share, vesting equally on March 31, June 30, September 30 and December 31, 2016 and expiring in January, 2026; (iv) options to purchase 33,937 shares of common stock at $0.285 per share expiring in January, 2021; (v) options to purchase 64,815 shares of common stock at $0.28 per share expiring in January 2026; (vi) options to purchase 30,000 shares of common stock at $0.25 per share expiring in May, 2021; (vii) options to purchase 150,000 shares of common stock at $0.25 per share expiring in May, 2021; (viii) options to purchase 60,000 shares of common stock at $0.25 per share expiring in August, 2026; (ix) options to purchase 140,000 shares of common stock at $0.25 expiring in May, 2022; (x) options to purchase 2,208,334 shares of common stock at $0.06 expiring in August, 2027; (xi) options to purchase 500,000 shares of common stock at $0.04 expiring in April, 2029; and (xii) June 2016 Warrants to purchase 100,100 shares of common stock at $0.25 expiring in 2021.
|
(6)
|
Mr. Levy’s holdings include: (i) options to purchase 100,000 shares of common stock at $1.66 per share expiring November, 2022; (ii) options to purchase 50,000 shares of common stock at $0.83 per share expiring in March, 2024; (iii) options to purchase 50,000 shares of common stock at $0.66 per share expiring in February, 2025; (iv) options to purchase 50,000 shares of common stock at $0.28 per share, and expiring in January, 2026; (v) options to purchase 51,170 shares of common stock at $0.285 per share expiring in January, 2026; (vi) options to purchase 80,000 shares of common stock at $0.28 per share expiring in January, 2021; (vii) options to purchase 37,500 shares of common stock at $0.25; (viii) options to purchase 70,000 shares of common stock at $0.25 expiring in August, 2026; (ix) options to purchase 120,000 shares of common stock expiring in May, 2022; (x) options to purchase 1,000,000 shares of common stock expiring in August, 2027; (x) options to purchase 500,000 shares of common stock at $0.04 per share expiring in April, 2029; (xi) June 2016 Warrants to purchase 100,100 shares of common stock at $0.25 expiring in June, 2021 and (xii) June 2018 Warrants to purchase 125,000 shares of common stock at $0.15 per share expiring in June 2021.
|
(7)
|
Mr. Scott’s holdings include: (i) warrants to purchase 210,210 shares of common stock at $0.25 per share expiring in June 2021; (ii) warrants to purchase 625,000 shares of common stock at $0.15 per share expiring in June 2021; and (iii) options to purchase 500,000 shares of common stock at $0.04 expiring in April, 2029.
|
(8)
|
Mr. Carney’s holdings include: (i) options to purchase 1,316,655 shares of common stock at $0.70 per share expiring in January, 2019; (ii) options to purchase 580,930 shares of common stock at $0.83 per share expiring in January, 2022; (iii) options to purchase 580,931 shares of common stock at $1.66 per share expiring in January, 2023; (iv) options to purchase 75,000 shares of common stock at $0.84 per share expiring in June, 2024; (v) options to purchase 16,665 shares of common stock at $0.68 per share expiring in February, 2025; (vi) options to purchase 248,344 shares of common stock at $0.24 per share expiring in March, 2021; (vii) options to purchase 375,000 shares of common stock at $0.16 per share expiring in August, 2019; and (viii) options to purchase 3,585,413 shares of common stock expiring in December, 2027.
|
(9)
|
IBS Capital LLC is deemed to be the beneficial owner of shares held by the funds it manages by virtue of the right to vote and dispose of such securities. The IBS Turnaround Fund (QP) (A Limited Partnership) owns (i) 15,252,583 shares of common stock; (ii) 6,998,917 shares of common stock issuable upon conversion of Series A Notes; (iii) options to purchase 49,820 shares of common stock at $0.21 per share expiring in January, 2021; (iv) June 2016 Warrants to purchase 244,745 shares of common stock at $0.25 expiring in June, 2021; (v) options to purchase 30,100 shares of common stock at $0.25 per share expiring in August, 2026; (vi) options to purchase 64,000 shares of common stock at $0.25 expiring May, 2022; and (vii) May 2017 Warrants to purchase 601,060 shares of common stock at $0.10 per share expiring in May, 2022.
The IBS Turnaround Fund, L.P. owns (i) 7,305,997 shares of common stock; (ii) 3,485,329 shares of common stock issuable upon conversion of the Series A Notes; (iii) options to purchase 25,175 shares of common stock at $0.21 expiring in January, 2021; (iv) June 2016 Warrants to purchase 124,625 shares of common stock at $0.25 per share expiring in June, 2021; (v) options to purchase 16,000 shares of common stock at $0.25 per share expiring in August, 2026; (vi) options to purchase 30,000 shares of common stock at $0.25 per share expiring in May, 2022; and (vii) May 2017 Warrants to purchase 124,625 shares of common stock at $0.10 per share expiring in May, 2022.
The IBS Opportunity Fund, Ltd. owns (i) 1,475,154 shares of common stock; (ii) 671,538 shares of common stock issuable upon conversion of the Series A Notes; (iii) options to purchase 6,400 shares of common stock at $0.21 per share expiring in January, 2021; (iv) June 2016 Warrants to purchase 31,000 shares of common stock at $0.25 per share expiring in June, 2021; (v) options to purchase 7,100 shares of common stock at $0.25 per share expiring in August, 2026; (vi) options to purchase 6,000 shares of common stock expiring in May, 2022; and (vii) May 2017 Warrants to purchase 58,401 shares of common stock at $0.10 per share expiring in May 2022.
|
The address of IBS Capital,
LLC is One International Place, 31st Floor, Boston, MA 02110
(10)
|
Samlyn Onshore Fund, LP owns (i) 4,027,973 shares of common stock, (ii) 12,821,072 shares of common stock issuable upon conversion of the Series A Notes, (iii) options to purchase 44,097 shares of common stock at $0.06 per share expiring in August, 2027, (iv) options to purchase 136,000 shares of common stock at $0.04 expiring in April, 2029 and (v) warrants to purchase 1,101,062 shares of common stock at $0.10 per share expiring in December, 2022. The reported securities are directly owned by Samlyn Onshore Fund, LP and may be deemed to be indirectly beneficially owned by (i) Samlyn Capital, LLC as the investment manager of Samlyn Onshore Fund, LP and (ii) Samlyn Partners, LLC (“Samlyn Partners”), as the general partner of Samlyn Onshore Fund, LP. The reported securities may also be deemed to be indirectly beneficially owned by Robert Pohly as the principal of Samlyn Capital, LLC and Managing Member of Samlyn Partners.
Samlyn Offshore Master Fund, Ltd. owns (i) 6,483,443 shares
of common stock, (ii) 24,021,093 shares of common stock issuable upon conversion of the Series A Notes, (iii) options to purchase
129,514 shares of common stock at $0.06 per share expiring in August, 2027, (iv) options to purchase 364,000 shares of common stock
at $0.04 expiring in April, 2029 and (v) warrants to purchase 2,062,909 shares of common stock at $0.10 per share expiring in December,
2022. The reported securities are directly owned by Samlyn Offshore Master Fund, Ltd.
and may be deemed to be indirectly beneficially owned by (i) Samlyn Capital, LLC as the investment manager of Samlyn Offshore Master
Fund, Ltd., and (ii) Robert Pohly as the principal of Samlyn Capital, LLC.
Samlyn Capital, LLC, Samlyn Partners and Robert Pohly disclaim beneficial ownership of the reported securities except to the extent of their respective pecuniary interests therein, and this report shall not be deemed an admission that any of them are the beneficial owners of the securities for purposes of Section 16 of the Exchange Act or for any other purpose. The address of
Samlyn Capital, LLC is 500 Park Avenue, New York, N.Y. 10022.
|
(11)
|
James Berylson is the sole managing member of Berylson Capital Partners, LLC, which manages the Berylson Master Fund, L.P. Of the 15,395,594 shares owned by the Berylson Master Fund, L.P., 11,293,118 shares are issuable upon conversion of Series 2023 Notes owned by the Berylson Master Fund, L.P. and 1,798,095 shares are issuable upon the exercise of May 2017 Warrants owned by the Berylson Master Fund, L.P. Mr. Berylson may be deemed to beneficially own the 16,668,594 shares. Mr. Berylson owns and additional 1,273,000 shares. The address of Berylson Capital Partners, LLC is 200 Clarendon Street, Boston, MA 02116.
|
(12)
|
Kingdon Capital Management, LLC is the beneficial owner of
shares of the Company, which are held by funds it manages by virtue of the right to vote and dispose of the securities. M. Kingdon
Offshore Master Fund, L.P. owns (i) 7,058,197 shares through the conversion of its ownership of Series 2023 Notes; (ii) 11,293,118
shares through the conversion of its ownership of the Series A Notes; (iii) 2,082,588 shares upon the exercise of the May 2017
Warrants; and (iv) options to purchase 277,777 shares of common stock at $0.11 per share expiring in June, 2023. Mark Kingdon
is the President of Kingdon Capital Management, LLC and may be deemed to beneficially own these shares. The address of Kingdon Capital
Management, LLC is 152 West 57th Street,
50th Floor, New York, N.Y. 10019,
|
(13)
|
Mr. Katayama is the President of Fimatec, LTD (Japan) a producer and distributor of specialty minerals. In March, 2016 Applied Minerals, Inc. and Fimatec LTD entered into an agreement in which Fimatec LTD agreed to be the exclusive distributor of the Company’s halloysite-based DRAGONITE for the Japanese market. In June, 2016 Fimatec LTD purchase 3,333,334 units from the Company in exchange for $500,000.
Each unit consisted of one share of common stock of the Company and a warrant to purchase 0.3 shares of the common stock of the Company with a whole share costing 3.3 warrants and $0.25. In August 2017, SK Logistics (Singapore) PTE LTD purchased 10,000,000 million units from the Company in exchange for $400,000. Each unit consisted of one share of common stock of the Company and a warrant to purchase 0.25 shares of common stock of the Company exercisable at $0.04 per share. Mr. Katayama is deemed to beneficially own these shares.
The address of each entity is Ochaanimizu Center Bldg, 5F 2-23-1 Kanda Awaji-cho Chiyoda-ku, Tokyo, Japan 101-0063.
|
(14)
|
Executive officer.
|
Section 16(a) beneficial Ownership Reporting Compliance
Section 16(a) of the Securities Exchange
Act of 1934 requires our officers, directors, and any person who beneficially owns more than 10% of our Common Stock to file reports
of ownership and changes in ownership with the Securities and Exchange Commission. Executive officers, directors, and more than
10% shareholders are required by regulation to furnish us with copies of all Section 16(a) forms which they file. To the best of
our knowledge, all filings were made timely in 2019.
Stockholder Proposals and Nominations for 2021 Annual
Meeting
No determination has been made as to when
the 2021 Annual Meeting will be held. We will file a Current Report on Form 8-K when that determination is made.
Proposals made under Rule 14a-8
Rule 14a-8 under the Securities Exchange Act indicates the date
or time frame, for purposes of Rule 14a-8, that a proposal must be submitted to the Company in order to be included in the Company’s
proxy statement and on the Company’s proxy card for the 2021 Annual Meeting. Under such rule, the proposals must be submitted
to the Company at our principal executive offices at P.O. Box 432, 1200 Silver City Road Eureka, UT 84628 by the following dates:
if the 2021 meeting is held within 30 days of the date of the anniversary of the 2020 Annual Meeting, a stockholder’s
Rule 14a-8 proposal must be received no later than the close of business on July 31, 2021; if it is held more than 30 days
from the date of the anniversary of the 2020 Annual Meeting of Stockholders, it must be received a reasonable time before the Company
begins to print and send its proxy materials for the 2021 Annual Meeting.
Proposals and Nominations made under
the Company’s By-Laws
The Company’s By-Laws provide means
for stockholders to submit proposals that are not submitted under SEC Rule 14a-8 or to make director nominations. Under the Company’s
By-Laws, stockholders who wish to submit proposals that are not submitted pursuant to SEC Rule 14a-8 or to make nominations for
the 2021 Annual Meeting must provide notice that is delivered to or mailed and received at the principal executive offices of the
Company:
|
(1)
|
by the close of business 60
days in advance of the anniversary of the 2020 Annual Meeting (which would be October 30, 2021) if such meeting is to be held
during the period November 30, 2021 to December 24, 2021;
|
|
(2)
|
90 days in advance (which would
be September 30, 2021, if such meeting is to be held on or after December 29, 2021 and on or before January 4, 2022; and
|
|
(3)
|
with respect to any other Annual
Meeting of Stockholders, the close of business on the tenth day following the date of public disclosure of the date of such meeting.
|
The Company will not consider at the 2020 Annual Meeting any
proposal or nomination that does not meet the requirements of Rule 14a-8 or the Bylaw requirements as the case may be.
Related Party Transactions
Our Board of Directors reviews any transaction, except for ordinary
business travel and entertainment, involving the Company and a related party before the transaction or upon any significant change
in the transaction or relationship. For these purposes, the term "related-party transaction" includes any transaction
required to be disclosed pursuant to Item 404 of Regulation S-K of the SEC
Equity Compensation Plan Information
Plans Approved by Stockholders
Shareholders approved the 2012 Long-Term
Incentive Plan (“2012 LTIP”) and the 2016 Incentive Plan. (“2016 IP”).
The number of shares subject to the 2012
LTIP for issuance or reference was 8,900,000. The number of shares subject to the 2016 IP was 15,000,000.
Plans Not Approved by Stockholders
Prior to the adoption of the November 2012
LTIP, the Company granted options to purchase 12,378,411 shares of common stock under individual arrangements.
In May and August, 2016, the Company adopted
the 2016 Long-Term Incentive Plan (“2016 LTIP”). The number of shares of common stock for issuance or for reference
purposes subject to the 2016 LTIP was 2,000,000. The Company granted options to purchase 1,993,655 shares of common stock under
the 2016 LTIP.
In 2017, prior to the adoption of the 2017
Incentive Plan (“2017 IP”) in August, 2017, the Company granted options to purchase 870,000 shares of common stock
under individual arrangements.
The number of shares of common stock for issuance or for reference
purposes subject to the 2017 IP was 40 million. The Company has granted options to purchase 39,245,288 shares of common stock under
the 2017 IP.
Equity Compensation Information
As of December 31, 2019
|
|
Number of
securities
to be issued upon
exercise of
outstanding
options
|
|
|
Weighted-
average
exercise price of
outstanding options
|
|
|
Number of
securities
remaining
available for
future issuance
under
equity
compensation
plans (excluding
securities
reflected in
column (a))
|
|
|
|
(a)
|
|
|
(b)
|
|
|
(c)
|
|
Equity compensation plans approved by security holders
|
|
|
13,903,249
|
(1)
|
|
$
|
0.59
|
|
|
|
9,996,751
|
|
Equity compensation plans not approved by security holders
|
|
|
46,773,319
|
(2)
|
|
$
|
0.17
|
|
|
|
201,334
|
|
Total
|
|
|
60,676,568
|
|
|
$
|
0.26
|
|
|
|
10,198,085
|
|
(1)
|
Includes 7,140,000 options granted under the 2016 IP and 6,763,249 options granted under the 2012 LTIP.
|
(2)
|
Includes 1,993,655 options granted under the 2016 LTIP, 39,805,011 options granted under the 2017 IP and 4,974,653 options granted under individual arrangements.
|
Part 7 Proposals to be voted on at the meeting
Proposal 1: Election of Directors
Five persons, all of whom are currently
directors, have been nominated for election at the Annual Meeting to hold office until the next Annual Meeting or until their respective
successors are elected and qualified or until they resign or are removed.
The directors will be elected by a plurality
of the votes cast, which means that the nominees receiving the largest number of “FOR” votes will be elected to the
open positions.
The Board of Directors has evaluated the
key attributes, experience, and skills of each nominee (set forth after biographical information of each nominee in “Information
about the Nominees” in Part 2) and has concluded on that basis that each nominee listed below should be re-nominated for
another term as director.
Name and Position
with The Company
|
Age
|
Director/Officer Since
|
|
Principal Occupation
|
|
|
|
|
|
Mario Concha
|
80
|
Chairman since 2016; Director since 2013
|
|
President, Mario Concha and Associates
|
|
|
|
|
|
John F. Levy
|
66
|
Vice Chairman since 2016; Director since 2008
|
|
CEO of Sticky Fingers Restaurant, LLC
|
|
|
|
|
|
Robert T. Betz
|
78
|
Director since 2014
|
|
Owner, Personal Care Ingredients
|
|
|
|
|
|
Geoffrey Scott
|
72
|
Director since June 2018
|
|
Private Investor
|
|
|
|
|
|
Christopher T. Carney
|
50
|
President and CEO since October 2020, Director since 2020
|
|
President, CEO and CFO of the Company
|
OUR BOARD OF DIRECTORS RECOMMENDS A VOTE
FOR THE ELECTION TO THE BOARD OF EACH
OF THE NOMINEES.
Proposal 2: Advisory Vote on Executive Compensation
As required by Section 14A of the
Securities and Exchange Act of 1934, we are asking for your approval of the following resolution (the “Say-on-Pay”
resolution):
RESOLVED, that the stockholders approve,
in a nonbinding vote, the compensation of the Company’s Named Executive Officers.
2017 Compensation
In March 2017, on recommendation of the Compensation Committee,
the Board determined the compensation of the Named Executive Officers would be as follows:
Mr. Zeitoun’s 2017 compensation was
as follows: salary — $350,000; cash receipts bonus — 4% of monthly gross cash receipts, up to a maximum bonus of $150,000;
revenue bonus — $100,000 if GAAP revenue exceeds $6 million; cash flow bonus — $100,000 if the Company is cash flow
positive for 2017.
Mr. Carney’s 2017 compensation was
as follows: salary — $150,000 per annum until August 15, 2017 and $200,000 thereafter; revenue bonus — $25,000 if
GAAP revenue exceeds $6 million; cash flow bonus — $25,000 if the Company is cash flow positive for 2017.
Mr. Gleeson’s 2017 compensation was
as follows: salary — $250,000; revenue bonus — $25,000 if GAAP revenue exceeds $6 million; cash flow bonus —
$25,000 if the Company is cash flow positive for 2017.
Mr. Zeitoun was paid the revenue bonuses.
Because the thresholds were not achieved, none of the other bonuses were paid to any Named Executive Officer.
On August 18, 2017, on the recommendation
of the Compensation Committee, the Board, in order that the Named Executive Officers would be properly motivated to take action
that would increase value for stockholders, granted options to Named Executive Officers as follows: Andre Zeitoun: 12,910,772 options;
Christopher Carney: 4,780,550 options; William Gleeson: 3,749,439 options. The options are ten-year options and the exercise price
is $0.06. Vesting conditions are as follows: (i) 25% of the options will vest upon the closing of the sale of an aggregate of $600,000
of units (consisting of one share of Common Stock and a warrant to purchase .25 of a share of Common Stock) at $.04 per unit (this
goal has been achieved); (ii) 25% of the options will vest upon the receipt of at least $900,000 from one or more of the following
sources: sale(s) of Common Stock over and above $600,000, consideration for entering into licensing or similar agreement(s), and/or
consideration for entering into agreement(s) relating to the sale or lease of minerals rights or entering into options or other
agreements relating mineral rights; (iii) 25% of the options will vest when the Company has toll processing arrangements with two
toll processors of halloysite that, in management’s good faith belief, can process halloysite to the Company’s specifications
(one of the agreements may be a back-up or standby arrangement); (iv) 8.3% of the options if EBITDA is positive over a period of
twelve months; (v) 8.3% of the options if EBITDA equals or exceeds $2 million over a period of twelve months; and (vi) 8.3% of
the options if EBITDA equals or exceeds $4 million over a period of twelve months. The vesting under the first three conditions
need not be sequential and the vesting under fourth and fifth or under the fourth, fifth, and sixth, or the fifth and sixth can
occur simultaneously. EBITDA is defined as operating income plus depreciation and amortization expense plus non-cash
expense plus any unusual, one-time expense incurred during the period.
The options were granted under the 2017
Incentive Plan, which was adopted on August 18, 2017 by the Board of Directors. Forty million shares of Common Stock are subject
to the plan.
On December 7, 2017, the Board of Directors,
on the recommendation of the Compensation Committee, granted to Mr. Zeitoun a bonus for service in 2017 of $120,000, and in particular
for work on amendments to the Series A and Series 2023 Notes and the BASF supply and tolling agreements, and to each of Mr. Carney
and Mr. Gleeson a bonus for service in 2017. The bonuses were paid in 2018
2018 Compensation
2018 salaries for the Named Executive Officers
are as follows: Mr. Zeitoun: $350,000; Mr. Carney: $200,000; Mr. Gleeson; $250,000. The Board, on recommendation of the Compensation
Committee, awarded bonuses for 2018 performance in the amount of $75,000 to Mr. Zeitoun and $20,000 each to Messrs. Carney and
Gleeson. The bonuses were paid in 2019.
In reaching its decisions for 2018 compensation,
the Compensation Committee and the Board took into account (i) the results vote the Say-on-Pay vote (93%) in favor, which suggested
that stockholders were generally favorable to the compensation scheme, (ii) the Company’s financial results and prospects
for generating revenues and the need to conserve capital, which led to no increase in salary, (iii) their efforts in connection
of the amendment of Series A and the Series 2023 notes and the sale of the waste piles for $4.5 million, which led to the bonus
and (iv) the options granted in 2017, which provided sufficient lion-term incentive, so that no more long-term incentive was deemed
necessary.
2019 Compensation
2019 salaries for the Named Executive Officers are as follows:
Mr. Zeitoun: $350,000; Mr. Carney: $200,000; Mr. Gleeson; $250,000 and Mr. Concha; $200,000.
In reaching its decisions, the Compensation Committee and the
Board took into account (i) the results of the most recent the Say-on-Pay vote (81% approval), which suggested that stockholders
were generally favorable to the compensation scheme, (ii) the Company’s financial results and prospects for generating revenues
and the need to conserve capital and (iii) the options granted to Messrs.. Zeitoun, Carney and Gleeson in 2017, which provided
sufficient long-term incentive so that no more long-term incentive was deemed necessary.
** * *
Approval of the advisory vote on executive
compensations requires a majority of votes cast.
OUR BOARD UNANIMOUSLY RECOMMENDS VOTING
“FOR” ON THE ADVISORY VOTE
ON EXECUTIVE COMPENSATION
Proposal 3: Ratification of Independent Auditor
The Audit Committee has selected MaloneBailey
LLP as the Company’s independent auditor for fiscal year 2020, and the Board asks stockholders to ratify that selection.
OUR BOARD OF DIRECTORS RECOMMENDS A VOTE
FOR RATIFICATION OF THE INDEPENDENT AUDITOR.
Part 8 Materials Incorporated by Reference
Accompanying this proxy statement are the
Company’s Annual Report on Form 10-K for the year ended December 31, 2019 and the Quarterly Report of Form 10-Q for the period
ended September 30, 2020
The following are incorporated by reference
to the Annual Report on Form 10-K for the year ended December 31, 2019 filed on June 1, 2020
|
·
|
Consolidated Financial Statements
and Supplementary Data
|
|
·
|
Management’s Discussion and Analysis of Financial Condition and Results of Operation
|
|
·
|
Qualitative and Quantitative Disclosure about Market Risk
|
|
·
|
Selected Financial Data
|
The following are incorporated by reference
to the Quarterly Report of Form 10-Q for the period ended September 30, 2020 filed on November 16, 2020
|
·
|
Consolidated Financial Statements and Supplementary Data
|
|
·
|
Management’s Discussion and Analysis of Financial Condition and Results of Operation
|
|
·
|
Qualitative and Quantitative Disclosure about Market Risk
|
Applied Minerals (CE) (USOTC:AMNL)
Historical Stock Chart
From Jan 2025 to Feb 2025
Applied Minerals (CE) (USOTC:AMNL)
Historical Stock Chart
From Feb 2024 to Feb 2025